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Ubiquitin is a small protein of 76 amino acids that is present in all eukaryotes and 
is highly conserved across the different species. For example, the human and yeast 
variants of ubiquitin differ by merely 3 amino acids and human ubiquitin is able to 
complement for the activity of yeast ubiquitin in a strain completely lacking all 
chromosomal copies of ubiquitin. In this project, alanine-scanning mutagenesis was 
performed with ubiquitin and histidine-tagged ubiquitin and the resulting alleles were 
expressed as the sole source of ubiquitin in yeast in order to isolate mutant ubiquitin 
alleles that displayed the various phenotypes investigated. In particular, the mutant 
ubiquitin alleles that were found to be severely deficient for growth on galactose media 
(gal
-
) were used for unbiased suppressor screens and GAL3 was identified as a suppressor 
of the gal
-
 phenotype of the H10-D58A ubiquitin mutant. As Gal3 is known to bind to 
Gal80 to relieve its effect on the activation domain of Gal4, Gal80 was investigated in 
detail and it was found that the deletion of GAL80 was able to fully suppress the gal
-
 
phenotype of the H10-Ub D58A mutant strain. Gal80 was subsequently found to be 
differentially degraded in glucose as compared to galactose and the increased stability of 
Gal80 was correlated with a lack of induction of GAL1 in the cells. The F-box protein 
Mdm30 was identified as being important for the poly-ubiquitination and subsequent 
degradation of Gal80 by the E3 ubiquitin ligase SCF
Mdm30
 and in the absence of MDM30, 
Gal80 remained stable upon galactose induction with a corresponding detrimental effect 
of the induction of GAL1 resulting in a gal
-
 phenotype that was once again completely 
rescued by the deletion of GAL80 in the cells. These results were further confirmed by 
viii 
 
the generation of a stable derivative of Gal80, the Gal80∆N12 mutant, which caused the 
cells expressing it to display a gal
-
 phenotype specifically due to the increased stability of 
the Gal80 derivative. The importance of Mdm30 in targeting Gal80 for degradation was 
further shown by the ability of Mdm30 to relieve the gal
-
 phenotype of cells over-
expressing Gal80 by eliminating the excess protein. The results presented here suggest 
that contrary to previous findings arguing that the degradation of Gal4 is necessary for 
the activation of the GAL genes, it is the degradation of the inhibitor Gal80 that is instead 
necessary for the activation of transcription. This would serve to reconcile the 
contradicting experiments that have thus far been published as it does not involve the 
degradation of Gal4 but instead the degradation of its inhibitor Gal80 and thus would 
explain why protein degradation is necessary for the activation of the GAL genes and why 
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ImageJ software (Abràmoff, 2011) and presented as a ratio of 
HA-Gal80/Coomassie. The ratio of HA-Gal80/Coomassie at 
time=0h in both glucose-grown and galactose-induced cells 
was set as 1 and the error bars indicate the standard deviations 
between two replicates. 
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Figure 3.22. Crystal structure of S. cerevisiae Gal80. The monomer of 
Gal80p is comprised of three domains. The N-terminal domain 
(in blue) consists of a Rossmann fold, the C-terminal domain 
(purple) with a prominent β-sheet forms the dimer interface, 
and a third domain (green) extends from the C-terminal 
domain toward the cleft. Disordered regions are shown as a 
dashed coil. From Kumar, P.R., Yu, Y., Sternglanz, R., 
Johnston, S.A., and Joshua-Tor, L. (2008). NADP regulates 
the yeast GAL induction system. Science. 319, 1090-1092. 
Reprinted with permission from AAAS. 
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Figure 3.23. Over-expression of Mdm30 suppressed the gal
-
 phenotype of 
cells over-expressing Gal80. Tenfold serial dilutions of (A) 
BY4741∆W or (B) SUB288∆WL + Ub WT cells expressing 
the indicated proteins were spotted onto the depicted plates 
and incubated at 28°C for 6 days to check for growth defects 
on galactose plates. The Galactose + AA plates contained 
1µg/ml AA. (EV: Empty Vector) 
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Figure 3.24. Schematic of the PGAL1-URA3 reporter construct. The URA3 
gene is cloned into a plasmid under the control of the GAL1 
promoter and Gal4 binds to the UASGAL1. (A) In the absence 
of Gal80, Gal4 is free to activate the URA3 gene. (B) When 
Gal80 is present, it binds to Gal4 and represses the expression 
of URA3. 
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Figure 3.25. Cells over-expressing Mdm30 displayed a glucose repression 
defect. Tenfold serial dilutions of BY4741∆W cells into which 
the PGAL1-URA3 reporter construct had been integrated 
expressing the indicated proteins were spotted onto the 
depicted plates and incubated at 28°C for 3 days to check for 





Figure 3.26. HA-Gal80 protein levels were significantly reduced upon 
over-expression of Mdm30. SUB288∆WL cells over-
expressing HA-Gal80 were transformed with either an empty 
vector or a plasmid over-expressing Mdm30. Cells were 
grown to OD600=1.0 before cell extract was prepared and a 
Western blot performed to check the levels of HA-Gal80 
present. Two different exposures of the same HA-Gal80 blot 
are provided for better visualization of the protein. 
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Figure 4.1. Model for transcriptional regulation of GAL1. Upon galactose 
induction, the Gal3 protein binds to Gal80 and relieves its 
inhibition of the Gal4AD to allow Gal4 to recruit the 
transcriptional machinery. It is proposed that in addition to the 
binding of Gal3 to Gal80, that Gal80 is degraded via the 
ubiquitin proteasome system to further deplete its levels in the 
nucleus and to enhance transcription of GAL1. 
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Figure 7.1. Comprehensive phenotype screen for the full list of mutant 
ubiquitin alleles. Tenfold serial dilutions of SUB288∆WL 
cells expressing the indicated ubiquitin alleles were spotted 
onto the depicted plates and incubated at for 6 days. The MMS 
plates contained 1mg/ml MMS, the AT plates contained 
50mM AT and the Gal + AA plates contained 1µg/ml AA. 
Controls for the gal
-
, AT and MMS phenotypes were included 
(∆GAL4, ∆GCN4 and ∆RAD5, respectively) 
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Figure 7.2. Comprehensive phenotype screen for galactose utilization 
deficient ubiquitin mutants. Tenfold serial dilutions of 
SUB288∆WL::GAL3 cells expressing the indicated ubiquitin 
alleles were spotted onto the depicted plates and incubated at 
28°C for 6 days. The Galactose + AA plates contained 1µg/ml 
AA. 
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Figure 7.3. Chromosome feature map showing the region of chromosome 
II encoded by the isolated suppressor. Gal1 is a galactokinase, 
it phosphorylates alpha-D-galactose to alpha-D-galactose-1-
phosphate in the first step of galactose catabolism and its 
expression is regulated by Gal4 
(http://www.yeastgenome.org/cgi-bin/locus.fpl?locus=gal1). 
The 5′ and 3′ ends of the DNA sequence coded for by the 
suppressor were identified by sequencing and the chromosome 






Figure 7.4. Chromosome feature map showing the region of chromosome 
IV encoded by the isolated suppressor. Gal3 is a 
transcriptional regulator involved in activation of the GAL 
genes in response to galactose; it forms a complex with Gal80 
to relieve Gal80 inhibition of Gal4; it binds galactose and ATP 
but does not have galactokinase activity 
(http://www.yeastgenome.org/cgi-bin/locus.fpl?locus=gal3). 
The 5′ and 3′ ends of the DNA sequence coded for by the 
suppressor were identified by sequencing and the chromosome 
feature map was retrieved from the Saccharomyces Genome 
Database (http://db.yeastgenome.org/cgi-bin/seqTools). 
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Figure 7.5. Chromosome feature map showing the region of chromosome 
XVI encoded by the isolated suppressor. Ypl257w is a 
putative protein of unknown function; thehomozygous diploid 
deletion strain exhibits a low budding index and it has been 
shown to physically interact with Hsp82; YPL257W is not an 
essential gene (http://www.yeastgenome.org/cgi-
bin/locus.fpl?dbid=S000006178). The 5′ and 3′ ends of the 
DNA sequence coded for by the suppressor were identified by 
sequencing and the chromosome feature map was retrieved 
from the Saccharomyces Genome Database 
(http://db.yeastgenome.org/cgi-bin/seqTools).  
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Figure 7.6. Chromosome feature maps showing the regions of 
chromosome IX encoded by the isolated suppressors. Rpl40a 
is a fusion protein, identical to Rpl40Bp, that is cleaved to 
yield ubiquitin and a ribosomal protein of the large (60S) 
ribosomal subunit with similarity to rat L40; ubiquitin may 
facilitate assembly of the ribosomal protein into ribosomes 
(http://www.yeastgenome.org/cgi-bin/locus.fpl?locus=rpl40a). 
The 5′ and 3′ ends of the DNA sequence coded for by the 
suppressor were identified by sequencing and the chromosome 
feature map was retrieved from the Saccharomyces Genome 
Database (http://db.yeastgenome.org/cgi-bin/seqTools). 
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Figure 7.7. Over-expression of Gal3 suppressed the gal
-
 phenotype of the 
histidine-tagged ubiquitin mutants. Tenfold serial dilutions of 
SUB288∆WL::GAL3 cells expressing the indicated ubiquitin 
alleles and either an empty vector (EV) or Gal3 were spotted 
onto the depicted plates and incubated at 28°C for 6 days. The 
Galactose + AA plates contained 1µg/ml AA.  
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Figure 7.8. Deletion of GAL80 suppressed the gal
-
 phenotype of the 
histidine-tagged ubiquitin mutants. Tenfold serial dilutions of 
SUB288∆WL::GAL3 or SUB288∆WL::GAL3 ∆GAL80 cells 
expressing the indicated ubiquitin alleles were spotted onto the 
depicted plates and incubated at 28°C for 6 days. The 





Figure 7.9. Gal80 was stable in cells expressing the histidine-tagged 
mutant ubiquitin alleles upon galactose induction. 
SUB288∆WL::GAL3 cells expressing the indicated histidine-
tagged mutant ubiquitin alleles together with HA-Gal80 were 
grown in glucose liquid media until OD600nm=1 before being 
induced in galactose liquid media for 1 hour. Cycloheximide 
(CHX) was added at time=0 and the amount of HA-Gal80 
protein remaining at each time point was determined by 
Western blot. The membranes were subsequently stripped and 
re-probed with α-CPY antibodies before being stripped once 
more and stained with Coomassie blue as loading controls 
before the bands were quantified using the ImageJ software 
(Abràmoff, 2011) and presented as a ratio of HA-Gal80/CPY. 
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Figure 7.10. Schematic of Gal80 showing its predicted domains. The 
predicted domains of Gal80 are highlighted and there is a 







Figure 7.11. Gal80 is degraded upon galactose induction in cells lacking 
Gal3. Tenfold serial dilutions of the indicated cells were 
spotted onto the depicted plates and incubated at 28°C for 6 
days to check for growth defects on galactose plates (A). 
BY4741∆W∆GAL3 cells expressing HA-Gal80 were grown in 
glucose liquid media until OD600nm=1 before being induced in 
galactose liquid media for 1 hour. Cycloheximide (CHX) was 
added at time=0 and the amount of HA-Gal80 protein 
remaining at each time point was determined by Western blot. 
The membranes were subsequently stripped and re-probed 
with α-CPY antibodies before being stripped once more and 
stained with Coomassie blue as loading controls (B) before the 
bands were quantified using the ImageJ software (Abràmoff, 
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1. LITERATURE REVIEW 
1.1. Yeast as a Model Eukaryote 
The baker’s yeast, Saccharomyces cerevisiae (S. cerevisiae) is often used as a model 
system for the study of eukaryotic cells and this is a major reason why it was the very 
first eukaryotic genome to be completely sequenced (Botstein et al., 1997; Goffeau et al., 
1996). The major advantages of using yeast as a model system are that it exists as a single 
cellular organism with either a haploid or diploid genome and has a fast growth rate and 
well characterized genetics, thus making it easy to culture and perhaps more importantly, 
convenient for use in making gene deletion strains for study (Botstein and Fink, 1988).  
A wide-range of shuttle vectors has been designed for use in yeast, making it possible 
to study the effects of the over-expression of either normal or mutant forms of proteins 
(Sikorski and Hieter, 1989). Well established protocols for performing homologous 
recombination also make it possible to introduce mutations or to tag proteins directly on 
the chromosome or even to delete entire genes altogether (Ausubel et al., 2012). Due to 
the ability of yeast to exist in either the haploid or diploid state, it is even possible to 
study the effects of recessive lethal mutations by introducing the mutations into diploid 
cells before inducing meiosis to generate haploid cells. Furthermore, there are a 
significant number of yeast genes which display homology to mammalian genes and it 
has been shown that certain mammalian genes are able to complement for the loss of 
their yeast homologs, something that we have also found to be the case with ubiquitin 
(Goffeau et al., 1996; Kataoka et al., 1985).  Taken together, these make S. cerevisiae an 
attractive tool for studying the workings of the eukaryotic system. 
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The study of phenotypes associated with mutations is one of the easiest and most 
common ways to genetically study mutant alleles and to identify suppressors to better 
understand genetic interactions and pathways (Hampsey, 1997). Two processes well 
known to be associated with ubiquitination are transcription and DNA repair (Daulny and 
Tansey, 2009; Hoege et al., 2002; Kao et al., 2004). In order to study these phenotypes, a 
number of methods can be applied. DNA repair pathways can be studied by investigating 
the ability of cells to survive following the induction of DNA damage by either exposing 
the cells to ultraviolet (UV) radiation or using a chemical such as methyl 
methanesulfonate (Downs et al., 2003; Huang and D’Andrea, 2006). Transcriptional 
defects can also be studied by a variety of methods. Temperature sensitivity phenotypes 
can be identified by incubating cells at either higher or lower temperatures than normal 
and are indicative of general transcription defects (Hampsey, 1997). In contrast, specific 
transcriptional defects can be studied by incorporating specific chemical inhibitors into 
the media. Growth defects in the absence of histidine and in the presence of 3-amino-
1,2,4-triazole (3-AT) are indicative of defects in transcriptional activation of the amino 
acid biosynthesis genes by Gcn4. 3-AT is a competitive inhibitor of 
imidazoleglycerolphosphate dehydratase, the product of the HIS3 gene, and in the 
presence of Gcn4 in wild-type cells, the transcription of HIS3 is sufficiently efficient that 
the cells can grow normally. However, under conditions where transcription is not fully 
activated, growth defects are often observed (Albrecht et al., 1998; Hope and Struhl, 
1986; Kanazawa et al., 1988). Besides the amino acid biosynthesis pathway, another well 
characterized transcriptional system in yeast is the GAL gene switch and transcriptional 
defects can be studied by observing growth defects on galactose media containing the 
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respiration inhibitor Antimycin A (AA). AA inhibits the electron transport chain and as a 
result causes the yeast cells to undergo fermentative growth. Under conditions where the 
GAL genes are not efficiently expressed, this translates into an observable growth defect 
when the cells are grown on galactose media (Goffrini et al., 2002; Hampsey, 1997; Lim 
et al., 2011). Apart from the few phenotypes mentioned here, there is still a wide range of 
phenotypes commonly used to genetically study mutant alleles, ranging from sensitivity 
to low temperatures or analogs, antibiotics and other drugs, to defects in cell morphology, 
stress responses and nucleic acid metabolism just to name a few, and those are covered in 
detail in a review by Hampsey (1997). 
 
1.2. Studying Transcriptional Regulation in Yeast 
Gene expression is the process by which the information encoded in genes is 
translated into the functional products such as RNA and proteins. This process is 
carefully regulated at a number of levels such as transcription, mRNA processing, 
trafficking and stability, translation of mRNA and finally protein stability. All these 
processes are vital to maintain homeostasis and erroneous gene expression can result in 
diseases such as Huntington’s disease and other neurodegenerative diseases as well as 
some cancers (Chahrour et al., 2008; Ciechanover and Schwartz, 2004; Congiu, et al., 
2009; Mani and Gelmann, 2005; Steffan et al., 2004).  
Transcription of DNA into mRNA is the first step in gene expression and is 
therefore very carefully regulated by a complex system of transcriptional activators and 
repressors. More importantly, many of the fundamental regulatory mechanisms are well 
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conserved among all eukaryotes, with many of the initial discoveries coming from work 
performed with yeast and later proven to be present in other eukaryotic systems, 
including mammals. In fact, some components of the highly conserved basic RNA 
polymerase II (pol II) are functionally interchangeable from yeast to man (Struhl, 1995).  
The TATA-box binding protein (TBP) is the most conserved eukaryotic 
transcription factor with about 80% of the C-terminal core domain conserved from yeast 
to man. TBP is known to bind to the TATA-box in the promoter region and to recruit the 
other general transcription factors such as TFIIA and TFIIB, which are vital in the 
formation of the pre-initiation complex (PIC). Interestingly, TBP has been shown to be 
important in mediating transcription of both promoters that contain a TATA-box 
sequence as well as TATA-less promoters. Furthermore, it has been shown that TBP is 
required for transcription by all three nuclear RNA polymerases, pol I, II and III, in yeast 
(Buratowski et al., 1989; Cormack and Struhl, 1992; Hahn and Young, 2011; Hernandez, 
1993; Struhl, 1995). In addition to TBP and the other general transcription factors, the 
two transcriptional co-activators, the SWI/SNF (switch/sucrose nonfermentable) complex 
and the SAGA (Spt-Ada-Gcn5-acetyltransferase) complex are usually also required for 
efficient transcription. The SWI/SNF complex has been shown to be important for 
chromatin remodeling by repositioning nucleosomes to allow access by RNA polymerase 
(Sudarsanam and Winston, 2000). More recently, it has also been shown that the 
SWI/SNF complex acts as a tumor suppressor by actively repressing certain genes and 
inactivating mutations in a number of SWI/SNF subunits have been associated with a 
variety of cancers (Wilson and Roberts, 2011). The SAGA complex on the other hand, is 
known to mediate transcription by acetylating histones through the activity of its Gcn5 
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subunit and also by regulating the interaction between TBP and the TATA-box (Sterner 
et al., 1999; Wu et al., 2004). Furthermore, the SAGA complex has been found to play an 
important role in transcription elongation and telomere maintenance in addition to protein 
stability. The SAGA complex also has deubiquitinase activity although the exact function 
of this activity is still unclear. Due to the fact that the SAGA complex is involved in 
mediating the transcription of genes such as c-Myc, p53 and E2F, defects in the complex 
have also been associated with cancer in humans (Koutelou et al., 2010). 
Another important co-activator complex is the Mediator complex that is well 
conserved from yeast to mammals and acts as an intermediate between the transcription 
regulators and the rest of the transcriptional machinery. Early evidence of the existence of 
the Mediator complex was provided when it was found that the over-expression of a 
transcriptional activator results in the inhibition of other genes. This indicates that the 
different activators might be limited by some common factor required for transcription 
(Gill and Ptashne, 1988). Soon after, a partially purified protein fraction was identified as 
being able to relieve the “squelching” effect of activators interfering with each other and 
the substance effecting this reversal was called the Mediator of transcriptional activity 
(Flanagan et al., 1991). The Mediator complex was later purified and shown to be 
required for both basal and activated transcription in a defined, reconstituted system (Kim 
et al., 1994). Since then, it has been found that the Mediator is a 25 subunit complex in 
yeast with nearly all of the subunits having homologs in insects and mammals (Bourbon 
et al., 2004; Conaway et al., 2005; Hahn and Young, 2011). In contrast, the human 
Mediator complex has about 30 subunits that have been identified to date and the 
complex has been found to exist in multiple forms that might be involved in regulating 
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different subsets of genes (Conaway et al., 2005). In addition to its ability to activate 
transcription by directly binding to transcriptional activation domains and pol II, the 
Mediator has also been found to have a role in stimulating basal transcription by 
stabilizing the PIC and the phosphorylation of the C-terminal domain of pol II and also to 
play a role in transcriptional repression (Hahn and Young, 2011; Kang et al., 2001; Malik 
and Roeder, 2005).  
The yeast Mediator complex can be classified into four distinct modules, namely 
the head, middle, tail and kinase modules (Boube et al., 2002; Bourbon, 2008; Hahn and 
Young, 2011). The head module, which consists of the Med6, Med8, Med11, Med17, 
Med18, Med20 and Med22 subunits has been proposed to play a general role in 
transcription and this is supported by the findings that it interacts with TBP and also 
stimulates basal transcription in vitro, possibly by controlling the interactions between the 
Mediator complex with RNA pol II as well as with the promoters (Bourbon, 2008; Hahn 
and Young, 2011; Takagi et al., 2006). The middle module consists of Med1, Med4, 
Med7, Med9, Med10, Med21 and Med31, and the tail module consists of Med2, Med3, 
Med5, Med15 and Med16 with the two modules being connected by Med14. The tail 
module has been shown to directly interact with transcriptional activators and repressors 
and the middle module is believed to transfer the regulatory inputs to the head module 
and the other general transcription factors (Bourbon, 2008; Hahn and Young, 2011; Han 
et al., 2001; Kang et al., 2001; Koschubs et al., 2010; Park et al., 2000). Finally, the 
kinase module consists of Med12 and Med13 along with the kinase Cdk8 and its partner 
CycC. This module is separable from the rest of the Mediator complex and has been 
found to be able to both activate and repress transcription possibly due to the ability of 
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Cdk8 to phosphorylate many transcriptional regulators (Bourbon, 2008; Chi et al., 2001; 







Figure 1.1. Schematic of the structure of the Mediator complex. The four modules of the 
Mediator complex are indicated: head (blue), middle (green), tail (red), kinase (orange). Cdk8 is 
also known as Srb10, CycC is also known as Srb11, Med15 is also known as Gal11 and Med21 is 




Ubiquitin is a small protein of 76 amino acids that is well conserved in all 
eukaryotes. For example, human and yeast ubiquitin differ by only three amino acids 
(Fig. 1.2). 
Score = 148 bits (374),  Expect = 8e-42,  
Identities = 73/76 (96%), Positives = 75/76 (99%), Gaps = 0/76 (0%) 
 
Human Ubiquitin  1   MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPP  38 
                     MQIFVKTLTGKTITLEVE SDTI+NVK+KIQDKEGIPP 
Yeast Ubiquitin  1   MQIFVKTLTGKTITLEVESSDTIDNVKSKIQDKEGIPP  38 
 
                 39  DQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG  76 
                     DQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG 





Figure 1.2. BLAST comparison of human and yeast ubiquitin. Human and yeast ubiquitin are 
shown to differ by only 3 amino acids. All seven lysines of ubiquitin are highlighted in red. 
 
Figure 1.3. Crystal structure of ubiquitin. All seven lysine residues are labeled and the relative 
abundance of poly-ubiquitin chains formed with each residue in vivo in Saccharomyces 
cerevisiae are indicated in red. Reproduced with permission, from Komander, 2009, Biochem. 
Soc. Trans., 37, 937-953. © the Biochemical Society. 
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Ubiquitin was first purified in 1974 by Goldstein while isolating thymopoeitin, a 
thymic hormone and it was subsequently detected in the cells of all the tissues that were 
studied and in a wide range of organisms such as animals, plants and yeast. Even more 
interesting was the fact that ubiquitin from the different organisms displayed close 
similarity by the functional, immunological and structural criteria used to study it, 
implying that ubiquitin was necessary for some essential function in order to be so well 
conserved over such a large evolutionary time span (Goldstein, 1974; Goldstein et al., 
1975; Schlesinger et al., 1975).  
Soon after, it was discovered that histone H2A was modified at Lysine 119 
(K119) by a non-histone chromosomal protein that was linked to it by an isopeptide bond 
and this protein was later identified as ubiquitin (Goldknopf et al., 1975; Olson et al., 
1976; Goldknopf and Busch, 1977; Hunt and Dayhoff, 1977). 
What propelled ubiquitin to the forefront of research however, was the finding 
that it was involved in the regulation of protein degradation. While it had been long 
known that proteins were degraded in the cell in an energy dependent manner (Simpson, 
1953), the exact mechanism of how this process was controlled was poorly understood 
until the 1980s. It was at that time when Ciechanover et al. (1978) discovered that a small 
heat stable polypeptide from reticulocyte lysates was necessary for ATP dependent 
proteolysis. This polypeptide was soon determined to be conjugated to its targets via an 
isopeptide bond in an ATP-dependent manner and shortly thereafter, it was identified as 
ubiquitin (Ciechanover et al., 1980a; Ciechanover et al., 1980b; Hershko et al., 1980; 
Wilkinson et al., 1980). 
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Since then, it has been determined that histones H1, H2A, H2B, H3 and H4 are all 
ubiquitinated in vivo (Zhang, 2003; Yan et al., 2009). Histone H2A is ubiquitinated at 
K119, while histone H2B is ubiquitinated at K120 (K123 in S. cerevisiae) (Goldknopf 
and Busch, 1977; Nickel and Davie, 1989; Thorne et al., 1987). More recently, 
ubiquitination of histone H4 has been mapped to K91 and this modification has been 
found to be important in the DNA damage response (Yan et al., 2009).   
Substrates can be ubiquitinated in a variety of ways. These include mono-
ubiquitination, multi-ubiquitination and poly-ubiquitination. Mono-ubiquitination 
involves the attachment of a single ubiquitin molecule to an internal lysine of the 
substrate, while multi-ubiquitination is the mono-ubiquitination of a substrate at multiple 
internal lysine residues. Poly-ubiquitination is where the first ubiquitin molecule is 
attached directly to a lysine of the substrate and additional ubiquitin molecules are 
attached to a lysine of the previous ubiquitin molecule. These poly-ubiquitin chains can 
be formed by attachment to any one of the seven internal lysines in ubiquitin but the best 
understood are the K48 and K63 linked poly-ubiquitin chains (Haglund and Dikic, 2005; 
Shang et al., 2005; Xu et al., 2009). K48 linked poly-ubiquitin chains are best known for 
their role in the ubiquitin proteasome system (UPS), which together with the lysosome 
are the main pathways for degrading proteins in the cell (Ciechanover, 2005; Mizushima 
and Komatsu, 2011). K63 linked poly-ubiquitin chains are associated with DNA repair, 
endocytosis and the activation of protein kinases, while multi-ubiquitination is associated 
with endocytosis. Mono-ubiquitination is best known for its role in histone regulation but 
has also been found to be important for endocytosis and cell signaling by facilitating 
interactions with proteins containing ubiquitin binding domains (UBD) (Emre et al., 
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2005; Haglund and Dikic, 2005; Huang and D’Andrea, 2006; Hurley et al., 2006; Polo et 
al., 2002). The functions of unconventional poly-ubiquitin chains formed using K6, K11, 
K27, K29 and K33 are still poorly understood but such linkages were found to be 
abundant in vivo and are likely to all be involved in targeting substrates for degradation 
(Komander, 2009; Xu et al., 2009) (Fig. 1.3). 
 
1.4. The Ubiquitin Proteasome System 
It had first been shown back in 1939 that proteins are in a dynamic state of 
degradation and synthesis when Schoenheimer et al. (1939) fed rats tyrosine synthesized 
with the nitrogen isotope N
15
. He later found that in addition to tyrosine carrying the 
nitrogen isotope being present in the tissue proteins of the rat, that the nitrogen isotope 
was also discovered incorporated into other amino acids such as arginine, histidine, 
aspartic acid and glutamic acid. This implied that the labeled tyrosine had been broken 
down into smaller components that were later used to synthesize new amino acids 
(Schoenheimer et al., 1939). The process was later found to be energy dependent when 
Simpson (1953) showed that labeled methionine-S
35
 and labeled leucine-3-C
14
 were 
released from rat liver protein slices in an energy dependent manner (Simpson, 1953). 
Soon after this, the discovery of the lysosome was initially thought to provide an answer 
as to how the degradation of proteins was regulated (Ashford and Porter, 1962; de Duve 
et al., 1953; Novikoff et al., 1956). However, it was difficult to reconcile the mechanism 
by which proteins were non-specifically degraded by the lysosome with the finding that 
different proteins could have half-lives ranging from a few hours to a few days and that 
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intracellular proteins continued to be degraded under conditions that inhibited lysosomal 
proteolysis (Dunn, 1994; Ohkuma et al., 1986; Schimke and Doyle, 1970). Therefore, 
these indicated that there had to be another mechanism by which proteins were degraded 
in cells and this conundrum was finally resolved with the discovery of the ubiquitin 
proteasome system (UPS) by Ciechanover et al. in 1978. 
The UPS protein degradation pathway is important in helping the cell to respond 
effectively and to survive cellular and environmental stress such as high temperatures and 
starvation (Finley et al., 1987; Özkaynak et al., 1987). Furthermore, protein substrates are 
each degraded at distinct and specific rates that vary under different conditions in order to 
ensure normal function. Variations of these degradation rates can cause disease either by 
the increased degradation of protein substrates resulting in a lower steady state level or 
conversely, the decreased degradation leading to an accumulation of toxic substrates 
(Hershko et al., 2000). As such, efficient and appropriate degradation of substrates is 
vital for normal cellular function. 
 
1.5. The 26S Proteasome  
With the discovery that proteins conjugated to ubiquitin are degraded, it was 
proposed that such substrates would be targeted by specific proteases that recognized the 
modified substrates (Hershko et al., 1980). A protease complex that specifically degraded 
ubiquitin-modified substrates in an ATP-dependent manner was later isolated and termed 
as a 26S protease complex based on its sedimentation coefficient (Hough et al., 1987). 
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Since then, it has been shown that the 26S proteasome is an essential component of 
the UPS (Hershko and Ciechanover, 1998; Voges et al., 1999). The 26S proteasome is 
made up of a 20S proteasome core containing the protease catalytic sites and two 19S 
regulatory particles, one at each end of the core (Fig. 1.4). The 20S proteasome core is 
made up of two copies each of seven distinct α-subunits and seven distinct β-subunits 
with each set of seven α- or β-subunits forming a seven-member ring which are 
assembled into a barrel-shaped particle with the two rings of β-subunits in the center and 
the two rings of α-subunits on the top and the bottom of the structure which has three 
internal chambers; two antechambers and one central proteolytic compartment (Peters, et 
al., 1993; Voges et al., 1999). Proteins targeted for degradation by the proteasome are 
effectively trapped by the core and only released once they have been cleaved to a certain 
length. Released peptides are between 4 and 25 amino acids in length and with an 
average length of 7-9 residues (Hershko and Ciechanover, 1998; Kisselev et al., 1998; 
Nussbaum et al., 1998; Voges et al., 1999). Antigenic peptides are then further processed 
and presented on major histocompatibility (MHC) class I molecules for recognition by 
the cytotoxic T lymphocytes as part of the immune response (Kloetzel and Ossendorp, 
2004; Rock and Goldberg, 1999). The 19S regulatory particles are important in 
recognizing and recruiting the ubiquitinated substrates to the 26S proteasome and are also 
involved in the unfolding of substrates and in translocating them into the 20S proteasome 
core for processing. Each 19S regulatory particle can be further classified into two 
subcomplexes, namely the base consisting of the six AAA-ATPase subunits (Rpt1-6) 
together with Rpn1 and Rpn2 and the lid, which is made up of 11 of the non-ATPase 
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In addition to the well characterized role of the 26S proteasome in proteolysis, it 
has also been reported that a subcomplex of the 19S regulatory particle might have a non-
proteolytic role in transcription elongation (Ferdous et al., 2001). This subcomplex has 
been termed as the AAA proteins independent of 20S (APIS) complex and has thus far 
been known to include the six AAA-ATPases of the 19S regulatory particle (Gonzalez et 
Figure 1.4. The 26S proteasome. The 26S proteasome consists of two 19S regulatory particles 
and the 20S proteasome core, one at each end of the 20S proteasome core. The 20S proteasome 
core is made up of two heptameric rings of β-subunits at the center with two heptameric rings of 
α-subunits at the top and bottom. The 19S proteasome is made up of the base consisting of the six 
AAA-ATPase subunits together with Rpn1 and Rpn2 and the lid, which is made up of 11 non-
ATPase subunits. (Based on Glickman et al., 1998) 
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al., 2002). In particular, it has been proposed that the APIS complex destabilizes the 
DNA-transactivator complex, possibly by unfolding the activator protein and as a result, 
blocks transcription. Gal4 was identified as one such target and interestingly, the 
destabilization of the Gal4 activator bound to DNA was later found to be counteracted by 
the mono-ubiquitination of its activation domain in a manner dependent on the 
hydrophobic patch of ubiquitin (Archer et al., 2008a; Archer et al., 2008b; Archer and 
Kodadek, 2009). 
 
1.6. Ubiquitination of Substrates  
Ubiquitination of substrates targeted for degradation is carried out through the 
attachment of the C-terminal G76 of the first ubiquitin molecule to the side chain of an 
internal lysine residue on a target protein with subsequent ubiquitin molecules attached to 
K48 of each additional ubiquitin molecule. This allows for recognition of the protein 
targeted for degradation by the 26S proteasome and ultimately its destruction (Eytan et 
al., 1993; Finley et al., 1994; Pickart, 2000). The ubiquitination of substrates occurs in 
three sequential steps. First, the ubiquitin C-terminus is activated through the formation 
of a thiol ester with the ubiquitin-activating enzyme, E1, via an ATP-dependent reaction. 
Next, the ubiquitin is transferred to a cysteine residue on an ubiquitin-conjugating 
enzyme, E2, before the ubiquitin is finally transferred from the E2 to the target protein 
catalyzed by a ligase, E3 (Fig. 1.5). Specific E2s and E3s have been shown to co-operate 
in the recognition of individual substrates of the protein degradation pathway (Beal et al., 
1996; Meusser et al., 2005; Tanaka et al., 2004; van Wijk et al., 2009; Xie and 
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Varshavsky, 2000). In S. cerevisiae, one E1, eleven E2s and 42 E3s have been identified 
to date and this number is significantly higher in humans with two E1s, 37 E2s and over 
600 E3s (Komander, 2009; Lee et al., 2008). This range of E2s and E3s coupled with the 
ability of the enzymes to form various combinations is what confers the high level of 






As is the case with many other post-translational modifications such as 
phosphorylation and acetylation, ubiquitination of substrates is also reversible and this 
deubiquitination is mediated by a group of proteases called deubiquitinating enzymes 
(DUBs). To date, 17 DUBs have been identified in yeast and nearly 100 in humans with 
the DUBs being grouped into five distinct subclasses. Four of these are thiol proteases: 
the ubiquitin C-terminal hydrolases (UCHs), ubiquitin-specific proteases (USPs), ovarian 
Figure 1.5. The ubiquitination process. The ubiquitin C-terminus is activated in an ATP 
dependent reaction through the formation of a thiol ester with an E1 ubiquitin-activating enzyme. 
The ubiquitin molecule is then transferred to an E2 ubiquitin-conjugating enzyme and then onto a 
lysine of the substrate in a reaction catalyzed by an E3 ubiquitin-ligase. A branched K48-linked 
poly-ubiquitin chain targets the substrate for degradation by the proteasome while a linear K63-
linked poly-ubiquitin chain targets a substrate towards non-proteolytic ends. (Based on Meusser 
et al., 2005). 
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tumor proteases (OTUs), and Machado-Joseph disease protein domain proteases (MJDs) 
and the last subclass is the Jab1/MPN metalloenzyme domain proteases (JAMM) which 
function as zinc-dependent metalloproteases (Amerik et al., 2000; Love et al., 2007; 
Reyes-Turcu et al., 2009; Wilkinson, 2009).  
The DUBs have several important roles to play in the ubiquitin system. Ubiquitin is 
known to be expressed as either a polymer consisting of multiple copies of ubiquitin or as 
a fusion protein with ubiquitin fused to a ribosomal protein. These proteins therefore need 
to be processed in order to generate free ubiquitin monomers (Baker and Board, 1987; 
Özkaynak et al., 1987). In addition, DUBs are needed to recycle ubiquitin polymers that 
have been detached from previously poly-ubiquitinated substrates, usually following the 
degradation of targets and the release of the ubiquitin polymers and also to free ubiquitin 
that are trapped with the thiol ester intermediates during the ubiquitination process 
(Amerik and Hochstrasser, 2004; Pickart and Rose, 1985). DUBs also function in 
reversing the mono- and poly-ubiquitination of substrates as part of the regulation of 
endocytic traffic and to save the ubiquitin molecules from getting degraded by the 
endosome in receptors targeted for degradation (Nijman et al., 2005). Finally, a 
proofreading mechanism has been proposed for rescuing inappropriately ubiquitinated 
substrates from degradation (Lam et al., 1997; Wilkinson, 1997). In all, the DUBs are 
exquisitely intertwined with the various functions of ubiquitin, and ubiquitination and 
deubiquitination often function as opposing pathways. However, the exact physiological 
roles of most DUBs have yet to be elucidated and whether this will continue to hold true 
remains to be seen.  
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The E3 ubiquitin ligases are subdivided into two main groups, namely the 
Homologous to E6-AP Carboxyl Terminal (HECT)-type E3s and the Really Interesting 
New Gene (RING)-finger-type E3s. The HECT E3s are characterized by a conserved 
cysteine residue in the ~350-residue HECT domain that forms an intermediate thioester 
bond with the C-terminus of ubiquitin before directly catalyzing the ubiquitination of the 
substrate (Metzger et al., 2012; Robinson and Ardley, 2004; Rotin and Kumar, 2009). In 
contrast, the RING-finger E3s are characterized by the sequence, C-X2-C-X(9-39)-C-X(1-3)-
H-X(2-3)-(C/H)-X2-C-X(4-48)-C-X2-C that is stabilized through the binding of two zinc 
atoms and they do not directly transfer ubiquitin to the substrate by forming a catalytic 
intermediate. Instead, they serve to facilitate the interaction between the E2 and the 
substrate resulting in the transfer of the ubiquitin molecule directly from the E2 to the 
target protein (Deshaies and Joazeiro, 2009; Metzger et al., 2012; Robinson and Ardley, 
2004; Rotin and Kumar, 2009).  
In the human genome, there are estimated to be over 600 E3s and of these, about 
95% are RING finger E3s. In comparison, there are an estimated 80 E3s in S. cerevisiae 
and thus, the relative abundance of E3s is approximately the same in both human and 
yeast (Li et al., 2008). RING finger E3s can be further classified into two types, namely 
those that are based on a single main component and those that are a complex made up of 
multiple components (Metzger et al., 2012; Robinson and Ardley, 2004). Of these, the 
Skp1-Cullin-F-box (SCF) complexes are the largest group and have been found to 
mediate the ubiquitination of a wide range of substrates (Zheng et al., 2002). The SCF 
complex consists of Skp1, Cul1, Rbx1 and an F-box protein. Rbx1 contains the RING 
domain that binds to the E2 and together with Cul1 makes up the catalytic core complex. 
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The F-box protein provides substrate specificity and the Skp1 protein acts as an adaptor 
to link the F-box protein to the catalytic core (Zheng et al., 2002) (Fig. 1.6). The S-phase 
kinase-associated protein (Skp1) was originally identified as a suppressor of the cdc4-1 
temperature sensitive mutant in which the Clb/Cdc28 kinase inhibitor Sic1, whose 
destruction is necessary for the cell to enter S phase, is stabilized. The over-expression of 
Skp1 in the cdc4-1 mutant served to significantly reduce the levels of Sic1 in the cells, 
indicating that Skp1 was somehow involved in its degradation. This then led to the 
discovery of the F-box motif that is conserved between cyclin F and Cdc4 and was found 
to be important for interaction with Skp1. This F-box motif was later shown to be 
important in recruiting specific substrates to the SCF complex with different F-box 
proteins binding to different substrates (Bai et al., 1996; Deshaies, 1999; Skowrya et al., 
1997). To date, there are an estimated 21 F-box proteins in S. cerevisiae and 68 in 
humans (Jin et al., 2004; Muratani et al., 2005).  Due to their importance in targeting 
specific substrates for degradation, aberrant expression of F-box proteins has been found 
to play a role in a wide-range of human diseases such as muscle atrophy as well as 
neurodegenerative diseases and various cancers (Gomez et al., 2001; Jin et al., 2004; 
Nelson and Laman, 2011). Furthermore, their ability to target specific substrates for 
degradation makes the F-box proteins attractive targets for drug development and there 
have been attempts to investigate the feasibility of designing chimeric F-box proteins as 








In addition to the E3 ubiquitin ligases, a new class of ubiquitin ligases termed the 
E4s has been proposed to exist and it is thought that they function in the elongation of 
ubiquitin chains on already ubiquitinated substrates (Koegl et al., 1999; Liu et al., 2010; 
Liu et al., 2011). However, this classification has been somewhat disputed by the finding 
that the founding member of the E4 ubiquitin ligases, Ufd2 can function as an E3 
ubiquitin ligase and that the U-box domain that is conserved among E4s is structurally 
similar to the RING finger domain, indicating that the E4 ubiquitin ligases might simply 
represent a new family of E3 ubiquitin ligases distinct from the HECT and RING-finger-
types (Hatakeyama and Nakayama, 2003; Metzger and Weissman, 2010; Tu et al., 2007). 
 
Figure 1.6. A schematic of an E3 ubiquitin-ligase. Rbx1 binds to the E2 and together with 
Cul1 forms the catalytic core of the E3. The F-box protein binds to a specific substrate and is in 
turn bound by Skp1 via the F-box motif to link the F-box protein and substrate to the catalytic 
core complex. The ubiquitin molecule can then be transferred directly from the E2 to the 
substrate. (Based on Zheng et al., 2002). 
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1.7. Degradation Signals (Degrons)  
  The levels of many proteins in the cell have to be regulated depending on the 
growth stage of the cell. As such, many proteins involved in the cell cycle, cell 
differentiation and stress responses are metabolically unstable. In order for the cell to 
effectively target specific proteins for differential degradation, they must each have some 
specific features by which they can be recognized. These are termed degradation signals 
or degrons (Varshavsky, 1991). 
 The earliest degradation signal to be discovered was the N-degron which is an N-
terminal residue of a protein that results in its destabilization. Taken together, the entire 
set of N-degrons resulting in different stabilities of the proteins was classified as the N-
end rule, where the in vivo half-life of a protein is related to its N-terminal residue 
(Varshavsky, 1992; Varshavsky, 1996). In general, amino acids with bulky or charged 
side chains are considered to be destabilizing but this varies between organisms and 
involves at least two determinants: a destabilizing N-terminal residue and an internal 
lysine for ubiquitination (Lévy et al., 1999; Meinnel et al., 2006; Varshavsky, 1996). The 
N-end rule has since been identified in bacteria, yeast, plants and mammals (Meinnel et 
al., 2006; Varshavsky, 1996). 
Following the discovery of the N-end rule, other degrons have also been identified. 
These include PEST sequences, N-terminal acetylation, N-terminal ubiquitination, cyclin 
destruction boxes and phosphorylation. N-terminal acetylation has been proposed to be 
an extension of the N-end rule pathway in that the N-terminally acetylated residues of a 
protein act as a secondary destabilizing residue which require the N-terminal residues of 
22 
 
a protein to be acetylated before they can be recognized by the E3 ubiquitin ligase Doa10 
and then be targeted for ubiquitination and degradation (Hwang et al., 2010). N-terminal 
ubiquitination, on the other hand, is distinct from the N-end rule whereby the N-terminal 
residue is directly modified by ubiquitination instead of being recognized and bound by 
an E3 ubiquitin ligase that targets an internal lysine on the protein substrate. Subsequent 
ubiquitin molecules are then attached to the N-terminal ubiquitin molecule for the 
formation of the poly-ubiquitin chain However, the physiological significance of this 
modification still remains to be discovered (Ciechanover and Ben-Saadon, 2004). In 
addition, it has been found that PEST sequences, which are regions rich in proline (P), 
glutamic acid (E), serine (S) and threonine (T), are commonly present in proteins with 
relatively short half-lives and that the deletion of these sequences serves to stabilize these 
proteins. These PEST sequences generally start and end with positively charged residues 
but internal lysine, arginine and histidine residues are not observed (Rogers et al., 1986; 
Shumway et al., 1999; Spencer et al., 2004). Besides these degrons, it has also been 
found that cyclins contain short sequences such as the 9-residue destruction motif called 
the D-box that is important in targeting the cyclins for degradation and that the 
phosphorylation of some cyclins is required for their ubiquitination by SCF complexes 
resulting in their degradation (Ravid and Hochstrasser, 2008; Yamano et al., 1998; 




1.8. Ubiquitination and Gene Expression  
Ubiquitination also plays an important role at many levels of gene expression. One 
of the first targets identified to be ubiquitinated was histone H2A and recent studies have 
shown that this modification is likely to be involved in silencing and transcriptional 
repression (Goldknopf and Busch, 1977; Wang et al., 2004; Zhou et al., 2008). In stark 
contrast, the ubiquitination and subsequent deubiquitination of histone H2B is necessary 
for the optimal induction of transcription (Henry et al., 2003; Kao et al., 2004) while at 
the same time, the mono-ubiquitination of lysine 123 of histone H2B in S. cerevisiae is 
important for transcription elongation and effects other histone modifications such as the 
methylation of lysine 4 of histone H3, which in required for the silencing of genes located 
near telomeres (Dover et al., 2002; Osley, 2006; Pavri et al., 2006). 
Besides the regulation of transcription by the ubiquitination of histones, ubiquitin is 
proposed to directly regulate the activation and inactivation of transcriptional activators 
in the cell through their mono-ubiquitination and subsequent poly-ubiquitination, 
eventually leading to their degradation (Kodadek et al., 2006). A major piece of evidence 
for this hypothesis was the finding that there is a significant overlap between the 
transcriptional activation domain (TAD) and the degron in many unstable transcription 
factors (Muratani and Tansey, 2003; Salghetti et al., 2000). Two distinct models have 
been proposed to explain how the activity of transcriptional activators is linked to 
ubiquitination and degradation, the Timer Model and the Black Widow Model (Kodadek 
et al., 2006). In the Timer Model, it is assumed that the mono-ubiquitination of the 
activator is necessary in order for transcription to initiate and that over time, additional 
ubiquitin molecules are added to form the poly-ubiquitin chain that will eventually signal 
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the degradation of the activator by the 26S proteasome. Some evidence to this regard has 
been presented by Archer et al. (2008b) who showed that the mono-ubiquitination of 
Gal4 is necessary for Gal4 to stably bind to the promoter. However, whether this mono-
ubiquitination eventually leads to poly-ubiquitination of Gal4 has thus far not been shown 
(Gonzalez et al., 2002; Kodadek et al., 2006). In contrast, the Black Widow Model 
proposes that the activator recruits the transcription machinery and as a result is modified 
in a manner that targets itself for poly-ubiquitination and subsequent degradation. This 
model was proposed based on experiments done with Gcn4, where the authors had found 
that upon transcriptional activation by Gcn4, the transcription machinery is recruited and 
Gcn4 is phosphorylated by the Mediator component Srb10 and this phosphorylation 
targets Gcn4 for poly-ubiquitination and degradation by the UPS, thus limiting the 
lifespan of the activator (Chi et al., 2001; Kodadek et al., 2006; Muratani and Tansey, 
2003; Tansey, 2001; Varshavsky, 1997). 
In addition to the classical degradation pathway through which ubiquitination can 
moderate the levels of the various proteins including transcription factors and repressors 
via the UPS, there is an expanding understanding of the involvement of ubiquitin in 
transcription regulation independent of the complete destruction of its targets. For 
example, the UPS has been implicated in the processing of transcription factors from 
their inactive precursors into the active forms (Hoppe et al., 2000; Palombella et al., 
1994).  
The transcription factor NF-κB which is present in nearly all cell types in humans 
and which is responsible for the activation of a diverse array of genes involved in cell 
adhesion as well as immune, stress and inflammatory responses is one good example of a 
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target significantly regulated by the UPS (Ghosh et al., 1998; Palombella et al., 1994; 
Smahi et al., 2002). The C-terminal half of the p105 precursor of the NF-κB p50 subunit 
needs to be ubiquitinated and degraded in order to generate the active form of the 
complex (Ghosh et al., 1998; Palombella et al., 1994). However, the active form of the 
complex is then prevented from entering the nucleus and activating transcription through 
interaction with its inhibitor, IκB, which binds to NF-κB and masks its nuclear 
localization signal (NLS), thus retaining it in the cytoplasm (Baldwin, 1996; Ghosh et al., 
1998; Karin and Ben-Neriah, 2000). Upon stimulation by stress signals or infection, IκB 
is quickly phosphorylated and subsequently poly-ubiquitinated by the SCF E3 ubiquitin 
ligase, SCF
β-TRCP
, eventually leading to its degradation by the 26S proteasome and the 
entry of NF-κB into the nucleus where it activates transcription of its target genes 
(Baldwin, 1996; Karin and Ben-Neriah, 2000; Strack et al., 2000). 
Yet another transcriptional activator that is regulated by ubiquitination is the tumor 
suppressor p53, which is important for mediating apoptosis and cell cycle arrest in 
response to cellular stress. This regulation is relatively complex as p53 and Mdm2 each 
serve to regulate each other. On one hand, p53 can activate the transcription of Mdm2 
and on the other hand, Mdm2 is known to bind to p53 to inhibit its activity resulting in a 
feedback loop. Furthermore, Mdm2 also has ubiquitin ligase activity and has been shown 
to mono-ubiquitinate or poly-ubiquitinate p53 depending on the abundance of both 
Mdm2 as well as a closely related protein, MdmX, with mono-ubiquitination of p53 
targeting it for nuclear export and poly-ubiquitination of p53 resulting in its degradation 
via the 26S proteasome (Li et al., 2003; Michael and Oren, 2003; Oren, 1999; Ouni et al., 
2011; Wang et al., 2011). 
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1.9. Non-Proteolytic Roles of Ubiquitination  
Besides its well characterized role in modulating the levels of cellular proteins via 
the UPS, ubiquitin has also been found to play an important role in cell signaling, 
endocytosis and the DNA damage response generally involving the poly-ubiquitination of 
substrates via K63 linked chains, as well as to function in transcription regulation 
independently of the degradation of its targets.   
One example by which ubiquitin can function independently of the degradation of 
its targets is in the ubiquitination of histones. As previously mentioned, histone H2A was 
the first protein to be identified as being ubiquitinated (Goldknopf et al., 1975). 
Unfortunately, due the absence of a similar modification being present in yeast, studies 
into the exact functions of H2A ubiquitination (ubH2A) have been somewhat limited 
(Hammond-Martel et al., 2012). In general, ubH2A has been associated with 
transcriptional repression such as in Polycomb silencing and ubH2A has been shown to 
be enriched on the inactive X chromosome (Xi) (Cao et al., 2005; Fang et al., 2004; 
Wang et al., 2004). ubH2A seems to impose its repressive effect on genes by interfering 
with transcriptional initiation by directly inhibiting the di- and tri-methylation of H3K4 
but much still remains to be discovered regarding the exact roles of ubH2A in gene 
expression (Nakagawa et al., 2008). In contrast, H2B ubiquitination (ubH2B) is 
conserved from yeast (K123) to human (K120) and it has been found associated with 
transcriptionally active regions and ongoing transcription (Davie and Murphy, 1990; 
Nickel et al., 1989). In addition, ubH2B was also found to be necessary for the di- and 
tri-methylation of H3K4 and H3K79 by Set1 and Dot1 possibly by regulating the 
transition from the mono-methylation to the di- and tri-methylated states (Schneider et 
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al., 2005; Shahbazian et al., 2005). ubH2B also directly influences chromatin dynamics 
during transcription elongation by reorganizing the nucleosomes into a looser and more 
dynamic structure to facilitate transcription as well as in regulating the reassembly of the 
nucleosomes to prevent cryptic transcription initiation (Fleming et al., 2008; Pavri et al., 
2006; Xin et al., 2009). Besides the ubiquitination of H2B, the deubiquitination of the 
histone is also important for optimal transcription as persistent ubH2B blocks the 
recruitment of the kinase Ctk1, which is important in the phosphorylation of RNA pol II 
to allow for transcriptional elongation (Wyce et al., 2007). In summary, the 
ubiquitination of histones has important roles to play in mediating chromatin structure 
and in the recruitment of downstream regulators necessary for activating or inhibiting 
transcription, and the ability of both ubH2A and ubH2B to affect the methylation of 
H3K4 indicates that there is some level of cross-talk between histones to reinforce their 
effects on gene expression (Hammond-Martel et al., 2012; Suganuma and Workman, 
2008). 
Besides the ubiquitination of histones, many substrates are also ubiquitinated 
without being targeted for degradation and one example of this is in the ubiquitination of 
cell-surface receptors. These ubiquitinated receptors are then recognized by the 
endosomal sorting complexes required for transport (ESCRT) machinery and internalized 
where they are sometimes targeted to the lysosomes for degradation (Duncan et al., 2006; 
Geetha et al., 2005; Ren and Hurley, 2010; Williams and Urbé, 2007). Cell signaling is 
yet another pathway that involves the ubiquitination of certain targets and this 
modification often leads to the activation of protein kinases that target specific substrates 
for phosphorylation. One of the best studied mechanisms of this is in the NF-κB pathway 
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where the IKK, the kinase that phosphorylates IκBα to target it for poly-ubiquitination 
and degradation is in turn activated by phosphorylation by TGF-β-activated kinase 
(TAK1) following the activation of TAK1 by poly-ubiquitination with K63-linked chains 
(Haglund and Dikic, 2005; Skaug et al., 2009). Ubiquitination is also involved in 
regulating many DNA repair processes, as the mutation of K63 on ubiquitin to arginine 
has been shown to sensitize cells to DNA damage as the poly-ubiquitination of certain 
targets is necessary for the recruitment of many DNA repair proteins to the site of the 
DNA damage. In particular, the replication factor that encircles DNA during replication, 
proliferating cell nuclear antigen (PCNA), has been shown to be mono-ubiquitinated at 
K164 upon encountering DNA damage with this triggering an error-prone replication 
pathway. Alternatively, PCNA can also be poly-ubiquitinated at the same residue via 
K63-linked chains and this induces error-free DNA replication. (Chen and Sun, 2009; 
Hofmann and Pickart, 1999; Moldovan et al., 2007). One common theme in many of 
these pathways is that the ubiquitinated substrates are generally poly-ubiquitinated by 
K63-linked chains, which do not target the substrates for degradation.  
The K63 linked chains are usually recognized in turn by a growing class of proteins 
that possess ubiquitin binding domains (UBDs) that serve to carry out the downstream 
processes including endocytosis, cell signaling and DNA repair as well as other processes 
such as targeting proteins for degradation and RNA splicing. To date, 20 distinct 
ubiquitin-binding domains (UBD, UIM, MIU, DUIM, UBA, CUE, GAT, VHS, NUB, 
NZF, ZnF_UBP, ZnF_A20, UBZ, UEV, Ubc, GLUE, PRU, UBM, SH3, PFU and 
Jab1/MPN) have been identified. Based on the importance of ubiquitin in a significant 
number of cellular processes, this number is likely to continue increasing (Chen and Sun, 
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2009; Hurley et al., 2006). Most UBDs bind weakly to ubiquitin, implying that additional 
interactions are required between the proteins and their targets in order to stabilize the 
interactions to be physiologically significant. Most of them interact with the hydrophobic 
patch on ubiquitin centered on Ile44. It has been proposed that each individual interaction 
is weak so as to prevent the constitutive blockage of binding sites by free ubiquitin 
present in the cell which would then prevent the UBD from binding to its ubiquitinated 
substrate (Chen and Sun, 2009; Haglund and Dikic, 2005; Hicke et al., 2005; Hurley et 
al., 2006; Komander et al., 2009).  
 
1.10. Ubiquitin-Like Proteins 
Apart from ubiquitin itself, there is a growing class of proteins that are related in 
sequence and possess a similar three-dimensional core structure to ubiquitin. These 
proteins have been referred to as the ubiquitin-like proteins (UBLs). These UBLs are 
similarly covalently linked to proteins via a cascade that is reminiscent of the 
ubiquitination process and are often recognized by other proteins in a manner similar to 
the recognition of ubiquitin modified substrates by the UBDs (Hochstrasser, 2009).  
The best studied of the UBLs to date is the small-ubiquitin-related modifier 
(SUMO) and it is known to be involved is a variety of cellular processes such as nuclear 
transport, transcription, DNA repair and chromosome segregation (Gareau and Lima, 
2010). In S. cerevisiae, the single SUMO coding gene is essential, but in mammals, four 
SUMO paralogs have been identified and the loss of any individual paralog does not 
seem to affect development (Wilkinson and Henley, 2010; Yuan et al., 2010). There is 
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also a growing group of proteins containing SUMO-interacting motifs (SIMs) that bind to 
SUMO via hydrophobic interactions and it has been proposed that the exact binding 
orientation might be specified by acidic amino acid residues along with phosphorylated 
serines neighboring the hydrophobic core of the SIMs  (Hecker et al., 2006; Kerscher, 
2007). SUMO is generally believed to be involved in transcriptional inhibition and it has 
been linked to heterochromatin formation through the SUMOylation of the methyl-CpG-
binding protein, MDB1 followed by the recruitment of MBD1-containing chromatin-
associated factor 1 (MCAF1) which is part of a chromatin remodeling complex that 
contains the histone methyltransferase SETBD1 and is proposed to methylate H3K9 
resulting in gene silencing and the formation of heterochromatin (Gill, 2005; Kouzarides, 
2007; Uchimura et al., 2006). In addition, SUMOylation of PCNA has been observed in 
the absence of DNA damage and this has been proposed to have a role in maintaining 
genome integrity by recruiting the helicase Srs2 to block recombination (Pfander et al., 
2005).  
Besides SUMO, a number of other ubiquitin-like proteins have also been 
identified. These include NEDD8, ISG15, FAT10, MNSFβ, UFM1, ATG8, ATG12, 
URM1 and HUB1. NEDD8 promotes ubiquitination by neddylation of cullins and ISG15 
was proposed to be important for the immune response against viral infections. FAT10 
and MNSFβ were both also proposed to have a function in the immune response, and the 
over-expression of FAT10 had previously been shown to inhibit cell proliferation and to 
promote apoptosis, while ATG8 and ATG12 are core components of the autophagy 
machinery (van der Veen and Ploegh, 2012; Welchman et al., 2005). It is interesting to 
note that in addition to the modification of proteins by ubiquitin, there is a significant 
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group of related molecules that utilize much of the same mechanisms. The ability of each 
of these modifications to potentially interact with multiple targets serves to underline the 
versatility of the ubiquitin and the UBLs in modifying proteins and much still remains to 
be discovered. 
 
1.11. Transcriptional Control of the GAL Genes 
One of the earliest model systems used to study transcriptional regulation is the 
GAL gene switch that is used by both S. cerevisiae and Kluyveromyces lactis in order to 
metabolize galactose, melibiose or lactose (Douglas and Condie, 1954; Douglas and 
Hawthorne, 1966; Johnston, 1987).  
The yeast GAL genes are classified into two main categories, namely, the 
regulatory genes and the structural genes. The structural genes include GAL1, GAL2, 
GAL7, GAL10 and MEL1 while the regulatory genes comprise the activator GAL4, the 
repressor GAL80, and the galactose sensor GAL3 (Lohr et al., 1995; Traven et al., 2006).  
The structural gene GAL2 is involved in the transport of galactose into the cell and 
the other genes catalyze the reactions in the Leloir pathway to convert galactose into the 
glycolytic substrate, glucose-1-phosphate (Lohr et al., 1995). The structural GAL genes 
are generally in one of three different states depending on the carbon source available. In 
the presence of glucose, the genes are repressed and in the presence of raffinose, they are 
in a de-repressed state. In both these states, the expression levels of the structural GAL 
genes are essentially undetectable. However, once exposed to galactose as the sole carbon 
source, the structural GAL genes are quickly and efficiently induced by up to 1,000-fold 
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(Diep et al., 2006; Johnston, 1987; Lohr et al., 1995). This strict regulation of the GAL 
genes is mediated by the regulatory GAL genes, GAL3, GAL4 and GAL80. The Gal4 
protein is a transcriptional activator that drives the transcription of all of the five 
structural GAL genes and has been shown to bind to the 17mer consensus UASGAL DNA 
sequence (5′-CGG-N11-CCG-3′) independently of galactose (Marmorstein et al., 1992; 
Traven et al., 2006). However, it is unable to activate transcription of the GAL genes in 
the absence of galactose due to the presence of the Gal80 repressor protein. In the 
absence of galactose such as when the cells are grown with glucose or raffinose, Gal80 
dimerizes and binds to the Gal4 activation domain (Gal4AD), physically blocking its 
interaction with the transcription machinery (Melcher and Xu, 2001; Pilauri et al., 2005). 
Upon galactose induction, this inhibition is relieved by the binding of Gal3 to Gal80 
(Peng and Hopper, 2000; Peng and Hopper, 2002; Platt and Reece, 1998). While it is 
clear that Gal3 binds to Gal80 in the presence of galactose and ATP, it is less clear what 
the exact mechanism by which Gal3 relieves the inhibition of Gal80 on the Gal4AD is. It 
had previously been proposed that the binding of Gal3 to Gal80 results in a 
conformational change resulting in the Gal4AD being freed up to allow it to recruit the 
transcriptional machinery. This theory is supported by the finding that Gal80 remains 
associated with Gal4 upon galactose induction (Bhaumik et al., 2004; Leuther and 
Johnston, 1992). In contrast, other studies have shown that Gal3 is found exclusively in 
the cytoplasm and that artificially tethering Gal3 in the cytoplasm does not block the 
quick induction of the GAL genes upon galactose induction (Jiang et al., 2009; Peng and 
Hopper, 2000; Peng and Hopper, 2002). However, this has been disputed by experiments 
showing that Gal3 interacts with Gal80 in both the nucleus as well as in the cytoplasm 
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(Wightman et al., 2008). Furthermore, it has recently been shown that nuclear Gal3 is 
important for rapid induction of the GAL genes and that Gal3, Gal80 and Gal4 form a 
short-lived complex soon after galactose is added to cells (Abramczyk et al., 2012; 
Egriboz et al., 2011). Taken together, these conflicting results clearly highlight the fact 
that there is still much to be discovered about the mechanisms involved in the GAL gene 
switch. 
In addition to the Gal80 repressor protein, the expression of the transcriptional 
activator Gal4 is repressed when the cells are grown in glucose media by the action of the 
Ssn6-Tup1 protein complex. This general repressor is recruited to a GC-rich, upstream 
repression sequence (URS) by the Mig1 protein and efficiently prevents expression of 
Gal4. Upon galactose induction, Mig1 is phosphorylated by Snf1 resulting in its 
translocation into the cytoplasm, allowing for the activation of the GAL genes (Lutfiyya 
and Johnston, 1996; Treitel and Carlson, 1995; Verma et al., 2005). At the same time, 
Gal4 has been shown to be targeted for degradation under non-inducing conditions by the 
F-box protein Grr1 and the absence of this F-box protein results in the activation of a 
GAL1-LacZ reporter gene in the absence of galactose. 
The Gal4 transcriptional activator is essential for the expression of the GAL genes, 
and cells deficient for Gal4 display a growth defect on galactose media (gal
-
 phenotype) 
(Matsumoto et al., 1978). Many proteins have been found to specifically interact with the 
Gal4AD including SWI/SNF, SAGA, Gal11, Srb4, Srb10 (Cdk8), TBP, TFIIB, Sug1 and 
Sug2 (Traven et al., 2006). The SWI/SNF complex is involved in chromatin remodeling, 
while the SAGA complex is a transcriptional co-activator that has been found to facilitate 
the binding of TBP to the core promoter (Bhaumik and Green, 2002; Biddick et al., 
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2008). Gal11, Srb4 and Srb10 are all components of the Mediator complex that is 
conserved from yeast to humans and is known to be important for transcriptional 
regulation (Boube et al., 2002; Kang et al., 2001; Kim et al., 1994). TBP (TATA-box 
binding protein) and TFIIB are both general transcription factors. TBP binds to the 
TATA-box and helps to direct the assembly of the pre-initiation complex (PIC), while 
TFIIB is involved in start site selection by RNA polymerase II (Wu et al., 1999). Based 
on current knowledge, the Tra1 subunit of the SAGA complex is the first protein to bind 
to the Gal4AD and the SAGA complex most likely helps to stabilize the binding of the 
Mediator complex, which is independently recruited to the UASGAL by Gal4 following 
which TBP is recruited together with the components of the PIC and the genes are 
activated for transcription (Bhaumik et al., 2004; Traven et al., 2006). The interactions 
between Sug1 and Sug2 with the Gal4AD are interesting because Sug1 (RPT6/CIM3) 
and Sug2 (RPT4) are both ATPases of the 19S regulatory particle of the 26S proteasome. 
However, the interaction seems to involve only a subset of the proteins of the 19S 
regulatory particle and this subset of interacting proteins seems to have a role in 
destabilizing the interaction between Gal4 and the UASGAL in a manner that can be 
countered by the mono-ubiquitination of Gal4 as opposed to targeting Gal4 for 
degradation (Archer et al., 2008b; Gonzalez et al., 2002; Russell and Johnston, 2001).  
Recent findings have presented a contradicting view on the role of ubiquitination 
and the UPS in the regulation of the GAL gene switch. Muratani et al. (2005) had shown 
that the deletion of the F-box protein Mdm30 resulted in the stabilization of Gal4 and a 
corresponding decrease in productive activation of GAL1 by Gal4. From their results, 
they concluded that the proteolytic degradation of Gal4 was necessary in order to 
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disassemble the initiation complex and to facilitate transcription and that this might be 
part of a mechanism to maintain appropriate levels of Gal4 at the target gene promoters. 
In contrast to these findings, Nalley et al. (2006) found that Gal4 remains stably bound to 
the promoter region upon galactose induction and that turnover of Gal4 was not required 
for transcriptional activation. As such, it is clear that even with all that is known about 
this classical transcription system, there still remain many interesting regulatory 
mechanisms waiting to be discovered. 
In this project, I performed alanine-scanning mutagenesis on ubiquitin to generate a 
complete set of ubiquitin point mutants each carrying a single amino acid substitution to 
alanine. These mutants were then investigated for deficient phenotypes and the H10-Ub 
D58A mutant was selected for use in a multi-copy suppressor screen where Gal3 was 
identified as a suppressor of the gal
-
 phenotype of the cells expressing H10-Ub D58A as 
its sole source of ubiquitin. As the gal
-
 phenotype observed was hypothesized to be the 
result of the stabilization of an unknown protein target in the ubiquitin mutant strain, the 
isolated suppressor, Gal3, was predicted to counteract the function of that unknown 
protein. As such, the antagonist of Gal3, the Gal80 repressor protein, was identified via a 










Table 2.1. Summary of yeast strains used in the project  
Strain Relevant Characteristics Source/ 
Reference 
Yeast (Saccharomyces cerevisiae) strains 
 




BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 Brachmann 
et al. (1998) 




BY4741∆W ∆GAL41 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 
YPL248c::kanMX4 TRP1::hisG 
This Study 
BY4741∆W ∆GCN4 1 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 
YEL009c::kanMX4 TRP1::hisG 
This Study 
BY4741∆W ∆RAD51 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 
YLR032w::kanMX4 TRP1::hisG 
This Study 
BY4741∆W ∆MDM301 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 
YLR368w::kanMX4 TRP1::hisG 
This Study 
BY4741∆W ∆DAS11 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 
YJL149w::kanMX4 TRP1::hisG 
This Study 
BY4730∆W ∆UFO11 MATa leu2∆0 met15∆0 ura3∆0 
YML088w::kanMX4 TRP1::hisG 
This Study 
BY4741∆W ∆GAL801 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 
YML051w::kanMX4 TRP1::hisG 
This Study 

























BY4742 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 Brachmann 
et al. (1998) 






 + pUB100 MATa lys2-801 leu2-3,112 ura3-52 his3-∆200 
trpl-1 ubil::TRP1 ubi2-∆2::ura3 ubi3-∆ub2 
ubi4-∆2::LEU2 
Finley et al. 
(1994) 
SUB288∆WL  MATa lys2-801 leu2-3,112 ura3-52 his3-∆200 






MATa lys2-801 leu2-3,112 ura3-52 his3-∆200 
trpl-1 ubil::TRP1::hisG ubi2-∆2::ura3 ubi3-
∆ub2 ubi4-∆2::LEU2::hisG 
This Study 
SUB288∆WL::GAL35 MATa lys2-801 leu2-3,112 ura3-52 his3-∆200 
trpl-1 ubil::TRP1::hisG ubi2-∆2::ura3 ubi3-




MATa lys2-801 leu2-3,112 ura3-52 his3-∆200 
trpl-1 ubil::TRP1::hisG ubi2-∆2::ura3 ubi3-





 MATa lys2-801 leu2-3,112 ura3-52 his3-∆200 




SUB300 ∆GAL802,5 MATa lys2-801 leu2-3,112 ura3-52 his3-∆200 











The BY4741 parental strains bearing chromosomal deletions of the various genes were obtained 
from EUROSCARF (European Saccharomyces cerevisiae Archive for Functional Analysis: 
www.uni-frankfurt.de/fb15/mikro/euroscarf/index.html) (Winzeler et al., 1999). The TRP1 gene 
was deleted with the help of pNKY1009 (Alani et al., 1987). 
 
2
GAL80 was deleted in the BY4741∆W ∆MDM30, BY4741∆W ∆GAL11, and SUB300 strains 
with the help of pNKY51-PTGAL80 (Alani et al., 1987). 
 
3
PGAL1-URA3 was integrated into the BY4741∆W with the help of the integrative plasmid pPGAL1-
304-URA3 (derived from pRS304: Sikorski and Hieter, 1989). 
 
4
The SUB288 strain was a kind gift from Daniel Finley, PhD (Harvard Medical School). The 
strain is a complete ubiquitin knock-out strain with all of its ubiquitin coding genes (UBI1, UBI2, 
UBI3, & UBI4) deleted. However, as ubiquitin is an essential gene, ubiquitin is expressed from a 
URA3-marked plasmid under the control of a strong promoter to compensate for the gene 
deletions. Additionally, as UBI1-3 exist as gene fusions of ubiquitin with essential ribosomal 
proteins, each of the three ubiquitin coding gene sequences were actually replaced with 
alternative genes while maintaining the ribosomal proteins. 
 
5
The SUB288 strain carries a frameshift mutation in the third codon of GAL3 that was identified 
by sequencing. The GAL3 gene was repaired in the SUB288∆WL strain by directly integrating 
GAL3 into the chromosome without the use of a selection marker while the gene was repaired in 
the SUB300 strain with the help of YIplac204-GAL3∆CNsiI (Gietz and Sugino, 1988). 
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Table 2.2. Summary of bacteria strains used in the project  
 
1DH5α E. coli cells were used for heat transformation of plasmids. 
2DH10β E. coli cells were used for electroporation of plasmids as they are more electro-
competent. 
 
Strain Relevant Characteristics Source/Reference 
Bacteria (Escherichia coli) strains 
DH5α1 F- Φ80dlacZ∆M15 ∆(lacZYA-





) phoA supE44 λ- 
thi
-





DH10β2 F- mcrA ∆(mrr-hsdRMS-mcrBC) 
Φ80dlacZ∆M15 ∆lacX74 recA1 
endA1 araD139∆(ara,leu)7697 























YIplac204-GAL3∆CNsiI Integrative Vector Amp
R
, TRP1 This Study 
YIplac128-Skp1-HA3H10 Integrative Vector Amp
R
, LEU2 This Study 
pPGAL1304-URA3 Integrative Vector Amp
R
, TRP1 This Study 
pNKY51-PTGAL80 Integrative Vector Amp
R
, URA3 This Study 
pNKY1009 Integrative Vector Amp
R
, TRP1 Alani et al. 
(1987) 
PactT315 Single-copy Vector Amp
R
, LEU2 Lab 
Collection 
PactT316 Single-copy Vector Amp
R
, URA3 Lab 
Collection 
PactT317 Single-copy Vector Amp
R
, LYS2 Lab 
Collection 
PactT315-Gal3 Single-copy Vector Amp
R
, LEU2 This Study 
PactT316-Ub WT Single-copy Vector Amp
R
, URA3 Lab 
Collection 
PactT316-HA-Gal80 Single-copy Vector Amp
R
, URA3 This Study 
PactT316-HA-Gal80∆N#3 Single-copy Vector AmpR, URA3 This Study 
PactT316-HA-Gal80 G301R Single-copy Vector Amp
R
, URA3 This Study 
PactT316-HA-Gal80 G323R Single-copy Vector Amp
R
, URA3 This Study 
PactT316-HA-Gal80 E351K Single-copy Vector Amp
R
, URA3 This Study 
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, LYS2 This Study 







, LYS2 This Study 
PactT424 Multi-copy Vector Amp
R
, TRP1 This Study 
PactT424-GST Multi-copy Vector Amp
R
, TRP1 This Study 
PactT424-GST-Gal80 Multi-copy Vector Amp
R
, TRP1 This Study 
PactT424-Ufo1 Multi-copy Vector Amp
R
, TRP1 This Study 
PactT424-Mdm30 Multi-copy Vector Amp
R
, TRP1 This Study 
PactT424-HA3-Mdm30 Multi-copy Vector Amp
R
, TRP1 This Study 
PactT423-HA3-Mdm30 Multi-copy Vector Amp
R
, HIS3 This Study 
 
1
BamHI site was used to clone Sau3AI partially digested yeast genomic DNA fragments to 
generate library plasmids Bank 13 (YEp13 genomic library), where each fragment could carry 
several open reading frames. 
 
2
PactT: Plasmid under the control of the actin promoter and terminator. 
 
3
The N-terminal residues were deleted from Gal80 in increments of 2 amino acids each, from 6 to 
20 amino acids (HA-Gal80∆N6-∆N20). 
 
4
The ubiquitin mutants were generated by introducing point mutations at the indicated residues 






Table 2.4. List of primers used for sequencing  
Primer Name Primer Sequence 
5′PACT1 + 60 5′ ATC TTC TAC TAC ATC AGC TT 3′ 
3′TACT1 - 60 5′ TTA TTT TAT TGA GAG GGT GG 3′ 
YEP13+ 5′ GCC ACT ATC GAC TAC GCG 3′ 
YEP13- 5′ GCG CCA GCA ACC GCA CCT GT 3′ 
 
Table 2.5. List of primers used in Real-Time PCR  
Primer Name Primer Sequence 
ACT1 Forward 5′ GAC CAA ACT ACT TAC AAC TCC A 3′ 
ACT1 Reverse 5′ CAT TCT TTC GGC AAT ACC TG 3′ 
GAL1 Forward 5′ ACT TGC ACC GGA AAG GTT TG 3′ 










Glu 2% (w/v) glucose media with complete amino acid premix. 
H- Glu 2% (w/v) glucose media with amino acid premix lacking histidine. 
K- Glu 2% (w/v) glucose media with amino acid premix lacking lysine. 
L- Glu 2% (w/v) glucose media with amino acid premix lacking leucine. 
U- Glu 2% (w/v) glucose media with amino acid premix lacking uracil. 
W- Glu 2% (w/v) glucose media with amino acid premix lacking tryptophan. 
HW- Glu 2% (w/v) glucose media with amino acid premix lacking histidine and tryptophan. 
WL- Glu 2% (w/v) glucose media with amino acid premix lacking tryptophan and leucine. 
UW- Glu 2% (w/v) glucose media with amino acid premix lacking uracil and tryptophan. 
Glu +  
5-FOA 
2% (w/v) glucose media with complete amino acid premix with 850mg/ml 5-Fluoroorotic 
acid (BioVectra) 
K- Glu +  
5-FOA 
2% (w/v) glucose media with amino acid premix lacking lysine with 850mg/ml 5-
Fluoroorotic acid (BioVectra) 
KW- Glu +  
5-FOA 
2% (w/v) glucose media with amino acid premix lacking lysine and tryptophan with 
850mg/ml 5-Fluoroorotic acid (BioVectra) 
Glu + MMS 2% (w/v) glucose media with complete amino acid premix with 1mg/ml Methyl 
methanesulfonate (Sigma) 
H- Glu + 
AT 
2% (w/v) glucose media with amino acid premix lacking histidine with 50mM 3-
Aminotriazole (Sigma) 
Raf 2% (w/v) raffinose media with complete amino acid premix. 
Gal 2% (w/v) galactose media with complete amino acid premix. 
L- Gal 2% (w/v) galactose media with amino acid premix lacking leucine. 
U- Gal 2% (w/v) galactose media with amino acid premix lacking uracil. 
W- Gal 2% (w/v) galactose media with amino acid premix lacking tryptophan. 
HW- Gal 2% (w/v) galactose media with amino acid premix lacking histidine and tryptophan. 
WL- Glu 2% (w/v) galactose media with amino acid premix lacking tryptophan and leucine. 
UW- Gal 2% (w/v) galactose media with amino acid premix lacking uracil and tryptophan. 
L- Gal + 
AA 
2% (w/v) galactose media with amino acid premix lacking leucine and 1µg/ml Antimycin A 
(Merck) 
U- Gal + 
AA 
2% (w/v) galactose media with amino acid premix lacking uracil and 1µg/ml Antimycin A 
(Merck) 
W- Gal + 
AA 
2% (w/v) galactose media with amino acid premix lacking tryptophan and 1µg/ml Antimycin 
A (Merck) 
Gal + AA 2% (w/v) galactose media with complete amino acid premix and 1µg/ml Antimycin A 
(Merck) 
LB + Amp Luria-Bertani media with 0.1mg/ml Ampicillin (Sigma) 
YPDA Yeast extract, Peptone, D-glucose, Adenine  
1Agar plates were prepared by the addition of 15g of Bacto Agar to minimal media and LB or 





2.2.1. Generation of Ubiquitin Point-Mutants 
The complete set of ubiquitin point mutants was generated via PCR mutagenesis. 
 
2.2.1.1. One-step PCR 
One-step PCR was carried out for the mutagenesis of amino acid residues near to 
the 5′ and 3′ ends of the ubiquitin gene (within 11 amino acid residues). The primers were 
designed by complementing 12 bases both before as well as after the bases targeted for 




The primers designed carried mutations within the codons to change the amino 
acids to alanine by changing the codons into “GCN” (the codons for alanine). PCR was 
then carried out by means of the primer carrying the desired mutation as well as either the 
EcoRI primer (5′-CACGAATTCGCGCAGATTTTCGTCAAGAC-3′) or the NotI primer 
Figure 2.1. Schematic of one-step PCR for mutation of amino acids near to 5′ & 3′ ends 
of ubiquitin. The top diagram shows the introduction of a mutation to the 5′ end of ubiquitin 
while the bottom diagram shows the introduction of a mutation to the 3′ end of ubiquitin. 
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(5′-GCCGCGGCCGCTAACCACCTCTTAGCCTTA-3′) as required. The denaturing 
temperature used was 95
o
C while the annealing temperature at which the best results 




2.2.1.2. Two-step PCR 
One-step PCR was not carried out for amino acids further than 11 amino acid 
residues away from the 3′ and 5′ ends of the ubiquitin gene as the lengths of the primers 
required would have been prohibitively expensive as well as difficult to generate 
accurately. As such, a two-step PCR strategy was carried out for those residues.  
In the two-step PCR, the primers were designed in the same manner as in the one-step 
PCR, except that a pair of the primers was generated for each mutation; one for each 
strand of parent DNA. The mutagenesis was then carried out in two separate reactions 
replicating the DNA upstream and downstream of the codon targeted for mutation. The 
two PCR fragments were then used as the template in a subsequent PCR reaction along 
with the addition of the EcoRI and NotI primers. Once again, the denaturing temperature 
used was 95
o
C, the annealing temperature was 30
o










After PCR mutagenesis, the products generated were cleaned up by means of the 
High Pure
TM
 PCR product purification kit. Both the PCR product as well as the PactT317 
vector was then digested with EcoRI and NotI overnight at 37
o
C. This was followed by 
another clean up step using the High Pure
TM
 PCR product purification kit and then a five 
hour ligation of the PCR product and the PactT317 vector before transformation into E. 





Figure 2.2. Schematic of the two-step PCR strategy. Step 1 shows the generation of the two 
mutant strands of ubiquitin and step 2 shows the combining of the two strands to generate the 
double stranded DNA of the mutant ubiquitin. 
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2.2.3. Histidine-Tagging of Ubiquitin Point Mutants 
Histidine-tagging of the ubiquitin point mutants was performed via subcloning of 
the EcoRI/NotI ubiquitin fragment into the PactT317-H20-Ub WT plasmid and amplified 
in E. coli DH5α (Koh, 2011). 
 
2.2.4. Plasmid Shuffling 
Ubiquitin is an essential gene and cells lacking it are not viable. As such, the 
SUB288ΔWL and SUB300 strains in which all chromosomal copies of the ubiquitin 
genes have been deleted express ubiquitin from a plasmid in order to support growth. 
This plasmid, PactT316-UbWT carries the URA3 gene as a selection marker. This is 
significant because the URA3 gene can also be used for counter selection of the plasmid.  
Following transformation of a plasmid expressing either a wild-type or mutant ubiquitin 
allele expressed from the PactT317 vector backbone, the cells are plated onto media 
lacking lysine in order to select for the PactT317-Ub plasmid. The cells can then be 
transferred onto media containing 5-fluoroorotic acid (5-FOA) to counter select for cells 
retaining the PactT316-UbWT plasmid as orotidine-5′-phosphate decarboxylase, which is 
the enzyme encoded for by the URA3 gene converts the 5-FOA into the toxic compound 
5-fluorouracil. Mutant ubiquitin alleles which are unable to complement for the loss of 
wild-type ubiquitin will result in the cells being unable to survive the plasmid shuffling 






2.2.5. Phenotyping (Droplet) Assay  
 As part of the plasmid shuffling procedure and also to study the phenotypes of the 




 were performed in sterile water using 
a 96-well plate. 5μl of each dilution was then spotted onto agar plates containing selective 
media as required and incubated at 28°C for three or six days as indicated. 
 
 
Figure 2.3. Schematic of the plasmid shuffling procedure in yeast cells. Yeast cells 
expressing wild-type ubiquitin on a URA3 marked plasmid are transformed with the mutant 
ubiquitin alleles on LYS2-marked plasmids. Cells are then plated on to media containing 5-
FOA. 5-FOA is converted to 5-fluorouracil in cells expressing the URA3 marked plasmid 
which is toxic to cells while cells expressing the LYS2 marked plasmids are able to survive. 
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2.2.6. Preparation of Competent Yeast Cells 
Yeast transformation was performed via the lithium acetate method (Becker and 
Lundblad, 2001). Before transformation was carried out, competent cells were first 
prepared by inoculating a single colony of the required yeast strain into 50ml of YPDA 
broth and incubated at 28°C with agitation to achieve an OD600nm=1. Following this, the 
cells were harvested by centrifuging at 3,220 x g for 5min and the cell pellet was washed 
with 0.1M lithium acetate (LiAc) solution and transferred to a microfuge tube. The cells 
were then centrifuged at 2,940 x g for 1min before the supernatant was discarded and the 
cells were re-suspended in 500μl of 0.1M LiAc solution. The cells were then incubated at 
28°C for 1hr followed by storage at 4°C for up to two weeks. 
 
2.2.7. Plasmid Transformation into Competent E. coli DH5α Cells   
Plasmids were amplified by mixing 15μl of DH5α cells with 5μl of ligation mix 
or 1μl of plasmid stock, and then incubating the mixture on ice for 30 minutes. This was 
followed by a heat shock at 42
oC for 90 seconds. 80 μl of LB broth was then added to the 
cells and they were incubated on a roller at 37
o
C for one hour to allow them to recover 
before 50μl of the sample was spread onto a LB agar plate with ampicillin to select for 
transformants. The agar plate was then incubated overnight at 37
o
C before colonies were 





2.2.8. Linearization of Plasmids for Homologous Recombination 
Transformation of yeast cells with plasmids used for integration required that the 
plasmids first be linearized in order for homologous recombination to occur efficiently. 
These plasmids were first digested with the appropriate restriction enzymes at 37°C for 
2hrs before being stored at -20°C until required. 
 
2.2.9. Plasmid Transformation into Competent Yeast Cells 
Transformation of plasmid into yeast cells was performed via the lithium acetate method 
(Becker and Lundblad, 2001). 2µl of Fish Sperm (FS) carrier DNA, 1µl of the 
appropriate plasmid DNA, 5µl of the appropriate competent yeast cells and 50µl of 40% 
(w/v) polyethylene glycol (PEG) solution were added in sequence in a sterile microfuge 
tube and mixed by vortexing. The mixture was then incubated at 28°C for 1hr, followed 
by heat shock in a 42°C water bath for 15min to trigger DNA uptake. Following this, the 
samples were centrifuged at 2,940 x g for 1min. The supernatant was then removed by 
aspiration and the cell pellet was re-suspended in sterile water and plated on appropriate 
selection media to select for positive transformants. 
 
2.2.10. Genetic Library Screening 
2.2.10.1. Transformation of Library Plasmids 
YEp13 library plasmids with a concentration of 0.5μg/μl were transformed into the 
SUB288∆WL yeast strain expressing the D58A ubiquitin mutant plasmid. 38μl of Fish 
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Sperm (FS) DNA, 12μl of YEp13 library plasmids, 50μl of competent yeast cells and 
500μl of 40% PEG were added in sequence to a microfuge tube and mixed by vortexing. 
The mixture was then incubated at 28°C for 1hr, followed by heat shock in a 42°C water 
bath for 15min to trigger DNA uptake. Following this, the samples were centrifuged at 
2,940 x g for 1min, the supernatant was removed by aspiration and the cells were re-
suspended in 250μl of sterile water. 
The cell re-suspension was plated evenly on one selective agar plate lacking leucine 
(L
-
) and incubated at 28°C for three days. The colonies that formed were washed off 
twice with 5ml sterile water each time, of which only 1% of the sample was plated on a 
selection plate and incubated for three days. The volumes of each transformation 
component and sterile water for re-suspension were multiplied according to the number 
of selection plates used. 
To screen for suppressors of the gal
-
 phenotype, the cells were plated onto complete 
galactose plates incorporating 1µg/ml antimycin A (AA) and incubated at 28°C for six 
days before potential suppressors were picked. 
In order to determine how many primary transformants were screened, two 
dilutions of the transformed cells were performed and plated on control L
-
 plates 
incubated at 28°C. 6μl cell re-suspension and 54μl sterile water were mixed, where only 
50μl was plated (1000X dilution) and 5μl 1000X diluted cell re-suspension and 45μl 
sterile water were mixed, where only 50μl was plated (10,000X dilution). The colony 




2.2.10.2. Plasmid Rescue from S. cerevisiae 
Colonies that had formed on the selection plates were picked and inoculated into 
5ml of L
-
 glucose broth to maintain selection pressure and incubated at 28°C with 
agitation until OD600nm = 1. 
The cells were then harvested, washed in sterile water and re-suspended in 200μl 
yeast breaking buffer. Next, a small amount of glass beads were added together with 
200μl 5:1 phenol/chloroform (pH4.7) before the mixture was vortexed for 5min to shear 
the yeast cells. The sample was centrifuged at 10,140 x g for 5min to separate the mixture 
into its individual components with the aqueous DNA at the top and the cell debris, 
phenol and glass beads at the bottom. Without disturbing the other phases, the top 
aqueous layer was carefully extracted using a pipette and transferred into a clean 
microfuge tube. The sample was centrifuged once again to remove any remaining 
contaminants and the aqueous layer was transferred into a clean microfuge tube. 500μl 
100% ethanol (EtOH) was added to precipitate the DNA and the tube was gently inverted 
to mix the contents. After centrifuging at 10,140 x g for 10min, the supernatant was 
removed. 200μl 0.3M sodium acetate (NaAc) was added, the tube was vortexed briefly to 
mix the contents and 500μl 100% EtOH was added before the tube was inverted to mix 
the contents. The sample was again centrifuged at 10,140 x g for 10min and the 
supernatant was removed. The pellet was washed with 700μl 70% EtOH, the mixture was 
centrifuged at 10,140 x g for 5min and the supernatant was removed. Finally, the plasmid 
DNA pellet was dried under vacuum for 30min and re-suspended in 100μl sterile water. 
The plasmid DNA was stored at -20°C. 
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A similar procedure was followed in order to confirm that each mutant ubiquitin 
allele shuffled into the SUB288ΔWL and SUB300 strains carried the indicated mutation 
whereby the plasmid rescue procedure was performed with cells expressing each mutant 
ubiquitin allele. The recovered plasmids were then amplified by PCR using the 5′ PACT1 + 
60 and 3′ TACT1 + 60 primers before being sequenced from both ends of the PCR 
fragment using either primer. 
 
2.2.10.3. Plasmid Transformation into Electro-competent E. coli DH10β Cells 
The electroporation cuvettes were prepared by overnight treatment with denatured 
EtOH, drying in a laminar hood, UV treatment for 10min and finally, cooling on ice for 
5min just before use.  
4μl yeast purified plasmid DNA and 40μl DH10β E. coli cells were mixed in a 
microfuge tube and cooled on ice before the mixture was carefully transferred into a 
prepared cuvette. The samples were electroporated at 1.8kV and 400μl Luria-Bertani 
(LB) broth was immediately vigorously mixed in. The mixture was transferred back into 
the microfuge tube and incubated at 37°C for 1hr after which the mixture was plated on 





2.2.10.4. Plasmid Preparation (Mini-Prep) 
Colonies were picked from the LB + ampicillin plate and inoculated into 2ml LB + 
ampicillin broth and incubated at 37°C for 12-16hr. The culture was transferred into a 
microfuge tube, centrifuged at 10,140 x g for 1min and the supernatant was removed. 
The cell pellet was re-suspended in 200μl Miniprep Solution I before Miniprep 
Solutions II and III were added in turn with gentle mixing to lyse the cells and precipitate 
the unwanted cellular products. The sample was then centrifuged at 10,140 x g for 5min, 
the supernatant transferred to a clean tube and 300μl isopropanol added followed by 
vigorous shaking to precipitate the DNA. The tubes were centrifuged at 10,140 x g for 
10min to pellet the DNA, the supernatant was removed and 500μl 70% EtOH was added 
to wash the cell pellet. The tube was centrifuged one final time at 10,140 x g for 5min 
before the supernatant was discarded and the plasmid DNA pellet was dried under 
vacuum for 15min and re-suspended in 50μl sterile water. The plasmid DNA was stored 
at -20°C. 
 
This procedure was also followed for the purification of plasmids from E. coli 





2.2.10.5. Confirmation of YEp13-Linked Phenotype Suppression 
In order to confirm that the YEp13 library plasmids had accounted for the 
suppression of the gal
-
 phenotype, the plasmids identified to be responsible for 
suppression were transformed back into the ubiquitin mutant and a droplet assay 




2.2.10.6. Testing for Ubiquitin-Mediated Phenotype Suppression (Plasmid Shuffling) 
As there are four ubiquitin coding genes on the yeast chromosome, one likely 
candidate mediating phenotype suppression would be ubiquitin. As such, the plasmid 
DNA purified from DH10β was transformed into SUB288∆WL + PactT316-Ub and 
plasmid shuffling was carried out to identify plasmids potentially carrying ubiquitin. 
 
2.2.10.7. Cycle Sequencing Reaction and Purification of Extension Products 
In a PCR tube, 3μl sterile water, 3μl isolated plasmids, 2μl YEP13+ or YEP13-
primer (1pmol/μl) and 2μl Big Dye (terminator ready reaction mix) were added in 
sequence and mixed. The following cycling parameters were then repeated for 25 cycles: 
96°C for 30s, 50°C for 15s and 60°C for 4min. The contents of the PCR tube was 
transferred to a microfuge tube containing 80μl of EtOH/NaAc solution consisting of 
14.5μl sterile water, 62.5μl non-denatured 95% EtOH and 3μl 3M sodium acetate (NaAc) 
solution (pH4.6). The mixture was vortexed briefly and left to stand at room temperature 
for 15min to precipitate the extension products. After centrifuging at 10,140 x g for 
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10min, the supernatant was carefully removed using a pipette and 500μl 75% EtOH was 
added to wash the pellet. The mixture was centrifuged at 10,140 x g for 5min, the 
supernatant was removed and the pellet was dried under vacuum for 15min before 
sequencing.  
The sequence was analyzed with WU-BLAST 2.0 available from Saccharomyces 
Genome Database (http://www.yeastgenome.org/cgi-bin/blast-sgd.pl) to determine the 
yeast genomic DNA fragments that were present on the YEp13 library plasmids. 
 
2.2.11. Cycloheximide Protein Stability Assay 
The stability of HA-Gal80 in glucose and galactose was assayed by the 
cycloheximide protein stability assay as cycloheximide (Sigma) inhibits protein synthesis 
in eukaryotic organisms (Hampsey, 1997). The required strains were transformed with 
PactT316-HA-Gal80, plated onto U
-
 media and incubated at 28°C for three days. 
Colonies of each were inoculated into 20ml U
-
 glucose or raffinose liquid media and 
incubated at 28°C until OD600nm =1. Cells from 10ml of culture were harvested, washed 
thoroughly with sterile water and induced in U
-
 galactose liquid media for 1hr. 0.02% w/v 
cycloheximide was added to both the glucose or raffinose and galactose cultures and 
samples were collected at 1hr intervals before a Western blot was done using α-HA 
antibodies to check the amount of HA-Gal80 present in the cells at each time point. The 
blots were then stripped and either re-probed with a α-CPY antibody or stained with 
Coomassie blue as a control. The protein bands were quantified using the ImageJ 
software (Abràmoff, 2004) and presented as a ratio of HA-Gal80/loading control. 
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2.2.12. Quantitative Real-Time PCR Analysis 
2.2.12.1. Purification of Total RNA 
RNA was purified using the RNeasy Mini Kit from Qiagen. 
Yeast cells were inoculated in differing volumes of either glucose or raffinose 
liquid media as required and incubated at 28°C until the culture density had reached 
OD600nm=1. 50ml of cells were then either harvested and the rest was washed thoroughly 
with sterile water and induced in galactose liquid media as required before 50ml was 
harvested for each time point. RNA was then prepared as per the manufacturer’s 
instructions and the RNA was stored at   -80°C. 
 
2.2.12.2. Quantification of Total RNA 
Total RNA was quantified by loading 1 μl total RNA onto a NanoDrop 
(NanoDrop
TM
 1000 Spectrophotometer) and directly taking the readings for RNA 
concentration in ng/μl. RNA purity was assessed from the ratio of absorbance at 260nm 
and 280nm whereby a 260/280 ratio of ~2.0 is generally regarded as being pure. 
 
2.2.12.3. Formaldehyde Agarose (FA) Gel Electrophoresis of Total RNA 
The RNA sample was prepared for FA gel electrophoresis by mixing 5μl total RNA 
with 5μl 2X RNA loading buffer (Fermentas). The mixture was incubated at 65°C for 
5min and chilled on ice before loading onto equilibrated FA gel. 1.2% FA gel was cast 
with 1.2g agarose, 10ml 10X FA gel buffer and topped up to 100ml with RNase-free 
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water before being heated to melt the agarose. 2μl ethidium bromide and 1.8ml 37% 
12.3M formaldehyde was added to the gel mixture before pouring onto a gel support. 
After loading a RNA marker (Fermentas) and the samples, the gel was electrophorized in 
a 1X FA gel running buffer at a constant 100V for 40min and viewed under UV light to 
analyze RNA integrity. Two sharp bands representing the 18S and 28S rRNA was 
indicative of intact RNA. 
 
2.2.12.4. DNase Treatment of DNA Contaminants 
2μl rDNaseI and 3.5μl rDNaseI buffer (Ambion) were added to 30μl of RNA 
diluted to a concentration of 100μg/ml and the mixture was incubated at 37°C for 2hr. 
The DNase treatment was then repeated by the addition of another 2μl rDNaseI followed 
by further incubation at 37°C for 2hr. Following this, 4μl DNase inactivation reagent was 
added and the mixture was incubated at room temperature for 2min. After centrifuging at 
10,140 x g for 2min, the supernatant was transferred into a clean microfuge tube and 
stored at -80°C. A PCR reaction was performed using the GAL1 primer pair to check for 
any remaining DNA contamination that would affect the Real-Time PCR.  
 
2.2.12.5. Reverse Transcription (RT)-PCR 
Reverse transcription PCR was carried out using the RevertAid
TM
 H Minus First 
Strand cDNA Synthesis Kit (Fermentas). In a PCR tube, 12μl RNase-free water, 10μl 
DNase treated total RNA, 2μl 50μM random hexamers, 4μl dNTPs, 8μl 5X RT buffer, 
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2μl RNase inhibitor and 2μl reverse transcriptase were added in sequence and mixed. The 
following cycling parameters were performed: -25°C for 10min, 42°C for 60min, 95°C 
for 5min. A PCR reaction was performed to analyze the quality of cDNA.  
 
2.2.12.6. Quantitative Real-Time PCR 
In quantitative real-time PCR, two pairs of reactions were prepared for each 
sample, with one pair containing ACT1 5′ and 3′ primers as controls and the other pair 
containing GAL1 open-reading frame (ORF) 5′ and 3′ primers.  
For both primer sets, 6.9μl RNase-free water and 5μl cDNA were added together 
with 0.3μl of each of the 5′ and 3′ primers and 12.5μl 2X SYBR Green before the 
samples were carefully mixed in 0.2ml MicroAmp
TM
 optical tubes and capped (Applied 
Biosystems). The ABI PRISM
®
 7000 Sequence Detection System (Applied Biosystems) 
was used and the samples were run at 50ºC for 2 min, 95ºC for 10 min, 95ºC for 15 sec 
and 60ºC for 1 min for 40 cycles before the samples were kept at 4ºC. Each measurement 
was performed thrice and the standard deviation was calculated. GAL1 mRNA was 






2.2.13. Pull-Down Assay  
2.2.13.1. Co-Immunoprecipitation (Co-IP) Protein-Protein Interaction 
In order to determine whether two proteins interacted in vivo, tagged forms of the 
appropriate proteins were either integrated into the chromosome or expressed from 
plasmids in BY4741∆W cells. The cells were then inoculated into 100ml of selective 
glucose liquid media as required and incubated at 28°C until the culture density had 
reached OD600nm=1. 50ml of cells were then harvested and the remainder was washed 
thoroughly with sterile water and induced in selective galactose liquid media for 2hr 
before being harvested. The cells were then re-suspended in 1000μl of yeast lysis buffer 
with 2mM phenylmethanesulphonylfluoride (PMSF) and transferred to a screw cap 
microfuge tube to which ~500μl of acid-treated glass beads had been added. The yeast 
cells were lysed in a Bead-Beater by agitating 3 times for 1min each with storage on ice 
for 2min in between treatments. The samples were then centrifuged at 10,140 x g for 
20min before the cell extracts were collected and 500μl of cell extract was added to 10μl 
of GST beads slurry that had been pre-equilibrated in 40μl of yeast lysis buffer. 2mM of 
PMSF was added and the sample incubated for 2hr at 4°C with gentle agitation to allow 
the GST-tagged proteins to bind to the beads. The samples were centrifuged at 845 x g 
for 2 min at 4°C and the supernatant removed. Unbound proteins were washed away by 
rinsing the beads 5 times with 1000μl fresh yeast lysis buffer with gentle agitation before 
20μl of 2X SDS loading dye (Bio-Rad) was added and the samples boiled at 95°C to 
denature and elute the bound proteins. The samples were then loaded on an 8% SDS-
PAGE gel and separated by electrophoresis. 
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Western blots were then performed and α-GST or α-HA antibodies used to probe 
for the presence of both the control and interacting proteins. 
 
2.2.13.2. Determination of Ubiquitination 
Yeast cells expressing histidine-tagged ubiquitin (PactT317-H10-Ub) were 
transformed with HA-tagged Gal80 (PactT316-HA-Gal80) and grown in 100ml of 
selective glucose liquid media untll OD600nm =1. 50ml of cells were then harvested and 
the remainder was washed thoroughly with sterile water and induced in selective 
galactose liquid media for 2hr before being harvested. The cells were then re-suspended 
in 1000μl of yeast breaking buffer with 2mM PMSF and transferred to a screw cap 
microfuge tube to which ~500μl of acid-treated glass beads had been added. The yeast 
cells were lysed in a Bead-Beater by agitating 3 times for 1min each with storage on ice 
for 2min in between treatments. The samples were then centrifuged at 10,140 x g for 
20min before the cell extracts were collected and 500μl of cell extract was added to 10μl 
of nickel (Ni
2+
) beads slurry pre-equilibrated in 40μl of yeast breaking buffer. 2mM of 
PMSF was added and the sample incubated for 2hr at 4°C with gentle agitation to allow 
the histidine-tagged proteins to bind to the beads. The samples were centrifuged at 845 x 
g for 2 min at 4°C and the supernatant removed. Unbound proteins were washed away by 
rinsing the beads 10 times with 1000μl fresh yeast breaking buffer with gentle agitation 
before the bound H10-Ub was eluted by the addition of 50μl of 500mM imidazole and 
incubation at 37°C for 1hr. The samples were then prepared for SGS-PAGE 
electropohoresis by mixing 20μl of sample with 20μl of 2X SDS loading dye (Bio-Rad) 
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and boiled at 95°C to denature the proteins before being loaded on an 8% SGS-PAGE gel 
and separated by electrophoresis. 
Western blots were then performed and α-HA antibodies used to probe for the 
presence of HA-Gal80. 
 
2.2.14. Western Blot Analysis 
To transfer proteins onto the nitrocellulose membranes, the Semi-Dry 
Electrophoretic Transfer Cell (Bio-Rad) system was used. Four pieces of filter paper 
were pre-soaked with freshly-prepared transfer buffer and placed onto the platinum anode 
before the pre-wet 0.2μm nitrocellulose membrane (Bio-Rad) was placed directly on top. 
The SDS-PAGE gel was stacked on top of the membrane followed by another four pieces 
of pre-soaked filter paper. The transfer was then carried out at 0.18A for 60min for one 
membrane or at 0.23A for 75min for two membranes. After the protein transfer process 
had completed, the membranes were blocked in 25ml of blocking buffer for 2hr with 
agitation. Subsequently, the blocking buffer was removed and the α-GST or α-HA 
primary antibodies were diluted 1:10,000 in 10ml of binding buffer before being 
incubated overnight at 4°C with agitation. The membrane was then washed three times 
with TBST for 15min each time before the α-Mouse horseradish peroxidase (HRP) 
secondary antibody, diluted 1:10,000 in binding buffer was added and the membrane 
incubated for 2hr at 4°C with agitation. The membrane was once again washed three 
times with TBST for 10min each time and loaded into the X-ray film cassette. The 
Amersham ECL Plus
TM
 or Amersham ECL
TM-
 Advance Western Blotting reagents (GE 
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Healthcare) were used as per manufacturer’s instructions and the CL-XPosure X-Ray 
Film (Thermo Scientific) was exposed to the signal from the membrane as required in a 
dark room.  
After the initial round of exposure, the membranes were washed for 10min with 
stripping buffer to remove the bound antibodies before they were blocked and probed 
with α-CPY antibodies diluted 1:10,000 in 10ml of binding buffer or directly stained with 
Coomassie blue as a control.  
Quantification of the Western blot bands were done using the ImageJ software 










3. RESULTS  
3.1. Alanine-scanning Mutagenesis of Ubiquitin  
Alanine-scanning mutagenesis whereby each amino acid residue of ubiquitin was 
mutated to alanine one-by-one was performed in order to study how each residue might 
be important for the overall function of the protein.  
PCR mutagenesis was performed to introduce the mutations into ubiquitin and the 
fragments were cloned into PactT317, a LYS2-marked single-copy vector containing the 
ACT1 promoter/terminator cassette. Each plasmid was sequenced in order to verify that 
the mutation had been successfully introduced and that the ubiquitin gene was still intact 
without any additional mutations. Subsequently, each ubiquitin allele was tagged with 10 
histidines (H10) at the N-terminus by sub-cloning each ubiquitin allele into a plasmid 










Figure 3.1. Multiple sequence alignment of the complete set of mutant ubiquitin alleles 
generated. The yellow highlighted region depicts the H10-tag while the pink diagonal line 
indicates the alanine mutation introduced into each mutant allele. Glycines which were not 
mutated to alanine are highlighted in green. Sequence alignment performed with ClustalW2 




Each plasmid was subsequently shuffled into the SUB288∆WL strain in which all 
chromosomal copies of ubiquitin had previously been deleted and expressed as the sole 






3.2. Complementation Assay of Mutant Ubiquitin Alleles 
Each plasmid containing a different mutant ubiquitin allele was introduced into the 
SUB288∆WL, SUB288∆WL::GAL3, and SUB300 strains. This was done by means of a 
technique called plasmid shuffling, which had previously been shown to be useful in 
identifying conditional mutations in essential genes (Fig. 2.3; Boeke et al., 1987). In 
these yeast strains, all four of the genes coding for ubiquitin had been deleted from the 
chromosomes and wild-type ubiquitin was expressed from a plasmid carrying URA3 as a 
selection marker. Upon introduction of the mutant ubiquitin allele on a different plasmid 
with a LYS2 selection marker, cells with the plasmid carrying the wild-type ubiquitin 
allele could be counter-selected for by plating the cells onto media containing 5-FOA, 
which is converted to the toxic compound 5-fluorouracil by the action of orotidine-5-
phosphate decarboxylase (URA3). Following plasmid shuffling, viable cells would 
express the mutant ubiquitin allele and inviable cells would be expected to have 
expressed a mutant ubiquitin allele incapable of complementing for the function of wild-
type ubiquitin. 
Each plasmid expressing a different mutant ubiquitin allele was transformed into 
the various yeast strains before the cells were plated onto media lacking lysine in order to 
select for the plasmids. Following this, a droplet assay was performed and the cells were 
plated onto media containing FOA in order to test for the ability of each mutant ubiquitin 








As can be seen in Figure 3.2, cells expressing the empty vector were unable to 
survive upon exposure to 5-FOA, as ubiquitin is an essential protein and the cells were 
unable to survive in its absence. In contrast, all three plasmids expressing the various 
ubiquitin alleles were able to support growth, albeit to different levels, possibly due to the 
H10-tag having a minor effect on the function of ubiquitin. Nonetheless, once the plasmid 
shuffling had been completed, the cells expressing the various ubiquitin alleles were 
found to grow at similar rates after they had been re-streaked and used in further 
experiments (Fig. 3.3B and Fig. 3.4).  
All the ubiquitin alleles that were capable of supporting growth when expressed as 
the sole source of ubiquitin in the cells were checked by recovery of the plasmids 
followed by sequencing to confirm the presence of the indicated point mutations. 
Surprisingly, even though ubiquitin is so highly conserved across the different 
species, there were merely 13 mutant alleles that were unable to complement the essential 
Figure 3.2. Representative result of the complementation assay. Plasmids expressing 
the indicated ubiquitin alleles were transformed into a yeast strain in which all 
chromosomal copies of ubiquitin had been removed and ubiquitin was expressed from a 
URA3-marked plasmid. Tenfold serial dilutions of each strain was spotted onto the 
depicted plates and incubated at 28°C for 3 days. Growth on the plate containing FOA 
indicated that the respective ubiquitin allele was capable of complementing for the 
essential functions of wild-type ubiquitin. (EV: Empty Vector) 
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functions of wild-type ubiquitin in the case of the untagged protein. As would be 
expected, this number increased to 22 mutant alleles being unable to complement the 
essential functions of wild-type ubiquitin after the H10 tag had been added. The summary 











 MQIFVKTLTG KTITLEVESS DTIDNVKSKI QDKEGIPPDQ 
Ubiquitin  ++++++-+  ++++++++++ +++++++++- ++++ -++++ 
H10-Ubiquitin  +-++++-+  ++++-+++++ ++-++--++- ++++ -++++ 
 QRLIFAGKQL EDGRTLSDYN IQKESTLHLV LRLRGG 
Ubiquitin ++--+  -++ ++ +++++-+ ++++++-+-- -+-- 
H10-Ubiquitin ++--+  -+- ++ ++-++-+ -+++-+-+-- -+-- 
Table 3.1. Summary of the complementation assay of the mutant ubiquitin alleles. Each 
mutant ubiquitin allele was tested for its ability to complement the essential functions of 
wild-type ubiquitin upon plating onto media containing 5-FOA. 
A “+” means that ubiquitin with an alanine substitution at that residue was able to 
complement the essential functions of wild-type ubiquitin, while a “-“ means that the 
ubiquitin with an alanine substitution at that residue was incapable of complementing the 
essential functions of wild-type ubiquitin. 
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3.3. Phenotype Assay of Mutant Ubiquitin Alleles 
Following the complementation assay, the cells were used for phenotypic assays in 
order to determine how the point mutations might affect the function of ubiquitin. 
Phenotypes originally studied included DNA repair defects, as well as general 
transcription defects and specific transcription activation defects. Growth defects in the 
presence of methyl methanesulfonate (MMS) are commonly used to identify phenotypes 
related to DNA damage as MMS methylates DNA. Temperature sensitivity (TS), on the 
other hand, is often an indicator of general transcription defects, while the use of selective 
agents such as 3-amino-1,2,4-triazole (3-AT) in the absence of histidine or galactose 
plates containing antimycin A (AA) can be used to investigate specific defects in 
transcriptional activation (Hampsey, 1997). 3-AT is a competitive inhibitor of 
imidazoleglycerolphosphate dehydratase, the product of the HIS3 gene. As such, when 
added to media lacking the amino acid histidine, 3-AT can be used to study defects in the 
amino acid biosynthesis pathway, as poor growth indicates that insufficient histidine is 
synthesized to sustain normal growth. Growth defects on galactose media containing AA 
is indicative of deficiencies in galactose utilization, as AA is a respiration inhibitor that is 
often used to simulate anaerobic conditions by inhibiting the electron transport chain, 
thus requiring that the cell is able to fully activate transcription of the GAL genes in order 
to grow normally. 
As shown in Figure 3.3A, cells expressing the various mutant ubiquitin alleles in 
place of wild-type ubiquitin displayed a variety of phenotypes on the different selection 
media used. This is indicative of the wide range of functions that involve ubiquitin 
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ranging from the DNA damage response to the regulation of transcription. However, the 
only ubiquitin point mutant that consistently displayed a strong gal
-
 phenotype was Ub 
Q2A, and this mutant grew slow under all conditions. In order to isolate strong ubiquitin 
alleles specific for the gal
-
 phenotype, the titrations on galactose + AA plates were 
repeated with the H10-tagged ubiquitin mutants. Figure 3.3B shows that H10-Ub I13A, 
R42A, F45A, D58A and T66A all displayed a strong gal
-
 phenotype on galactose + AA 
plates, with H10-Ub D58A also being unable to grow on galactose plates under aerobic 
conditions. The complete phenotype assay performed with the full list of ubiquitin 
mutants is presented in Figure 7.1 and the complete phenotype assay of the histidine-
tagged ubiquitin mutants to identify strong ubiquitin alleles specific for the gal
-
 








While the GAL gene switch has been extensively studied and is one of the best 
characterized systems of transcriptional regulation in eukaryotes, much still remains to be 
discovered. For example, there is still significant debate as to how exactly the GAL genes 
are activated, in particular with respect to the regulation of the transcriptional activator 
Gal4. In particular, there has been contradictory data presented as to whether Gal4 needs 
to be degraded in order to allow for the activation of the GAL genes (Muratani et al., 
2005; Nalley et al., 2006). As such, we decided that it would be interesting to investigate 
how ubiquitin is involved in the activation of the GAL gene switch.  
Figure 3.3. Phenotyping of untagged and H10-tagged ubiquitin mutants. Tenfold serial 
dilutions of the indicated ubiquitin alleles expressed in SUB288∆WL + Ub (A) or 
SUB288∆WL::GAL3 + H10-Ub (B) were spotted onto the depicted plates and incubated for six 
days. The MMS plates contained 1mg/ml MMS, the AT plates contained 50mM AT and the Gal 
+ AA plates contained 1µg/ml AA. Controls for the gal
-
, AT and MMS phenotypes were 




3.4. Library Screening for Multi-Copy Suppressors of the gal
-
 Phenotype of 
Ubiquitin Mutants 
Following the phenotype assay, a suppressor screen was performed whereby a 
multi-copy library of all the yeast genes was transformed into the cells before the cells 
were spread onto galactose plates containing AA in order to isolate any genes that were 




Initial Screen  ~100,000 Transformants Screened, 
67 Suppressors Picked  
Re-screen  11 Plasmid-Linked Suppressors  
Complementation Assay  
(Test for Ubiquitin)  
8 Non-Ubiquitin Plasmids 
(3 Ubiquitin)  
Sequencing  
 
II – 278860-285328 (GAL1)   
IV – 463104-466549 (GAL3)  
XVI – 59756-65831 (YPL257W) 
IX – 65247-73762/66859-73762 (2xRPL40A/UBI1) 
Sequencing Unsuccessful for 3 Samples 
 
From the suppressor screen, a number of genes were identified (Table 3.2, Figs. 
7.3-7.6). In particular, it is important to note that wild-type ubiquitin was identified 
among the suppressors isolated. This is significant as it serves to validate the suppressor 
screen because wild-type ubiquitin would naturally be able to complement for any growth 
defects resulting from the mutant ubiquitin alleles and the inability to identify wild-type 
ubiquitin as a suppressor would indicate that the screening protocol used may not be 
Table 3.2. Summary of the suppressor screen. Summary of the results of the multi-copy 
suppressor screen performed to identify suppressors of the gal- phenotype of the H10-Ub D58A 
ubiquitin mutant. Suppressors were picked in an initial screen and subsequently re-screened to 
confirm the suppression of the gal- phenotype. A complementation assay was then performed 
to test for plasmids expressing ubiquitin before the non-ubiquitin plasmids were sequenced. 
The genomic locus of each isolated suppressor fragment is indicated and the suppressor gene is 
given in brackets. The genomic maps for each suppressor are provided in Appendix A. 
 
Initial Screen  ~100,000 Transformants Screened, 
67 Suppressors Picked  
Re-screen  11 Plasmid-Linked Suppressors  
Complementation Assay (Test for 
Ubiquitin)  
8 Non-Ubiquitin Plasmids 
(3 Ubiquitin)  
Sequencing  
 
II – 278860-28 328 (GAL1)   
IV – 463104-466549 (GAL3)  
XVI – 59756-65831 (YPL257W) 
IX – 65247-73762/66859-73762 
(2xRPL40A/UBI1) 
Sequencing Unsuccessful for 3 Samples 
 Table 3.2. Summary of the suppressor screen. Summary of the results of the multi-copy 
suppressor screen to identify suppressors of the gal
-
 phenotype of the H10-Ub D58A ubiquitin 
mutant. Suppressors were picked in an initial screen and subsequently re-screened to confirm 
the suppression of the gal
-
 phenotype. A complementation assay was then performed to test for 
plasmids expressing ubiquitin before the non-ubiquitin plasmids were sequenced. The genomic 
locus of each suppressor is indicated and the suppressor gene is given in brackets. 
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sufficiently comprehensive. Besides the isolation of wild-type ubiquitin, GAL1, GAL3 
and YPL257W were also identified as suppressors of the gal
-
 phenotype (Fig. 7.3, Fig. 7.4 
and Fig. 7.5). Gal1 is a galactokinase that catalyzes the first step of the Leloir pathway by 
which galactose is metabolized in yeast and has also been shown to possess Gal3-like 
induction activity when over-expressed while Gal3 is a galactose sensor (Bhat et al., 
1990; Bhat and Hopper, 1992; Johnston, 1987; Lohr et al., 1995). In contrast, YPL257W 
is an uncharacterized ORF coding for a putative, non-essential protein of unknown 
function (Zettel et al., 2003). 
Of particular interest was the isolation of GAL3, a transcriptional regulator involved 
in the activation of the GAL gene switch. Gal3 is important for the induction of the GAL 
genes and in the presence of galactose, Gal3 binds to the GAL repressor protein Gal80 
and relieves its inhibition of the Gal4AD (Gal4 Activation Domain). However, the exact 
mechanism by which this relief of inhibition is achieved is poorly understood to date and 
conflicting results have been presented. It is hoped that the data presented in this thesis 
might help to explain some of these conflicting results and therefore help us to better 
understand how transcription is regulated in eukaryotic cells. 
As previously mentioned, the main function of Gal3 is in its binding to Gal80 to 
relieve its inhibitory effect on the Gal4AD. Since the over-expression of Gal3 suppressed 
the gal
-
 phenotype displayed by the ubiquitin mutant, we hypothesized that the gal
-
 
phenotype observed might have been due to an excess of Gal80. The over-expression of 
Gal3 would result in increased binding of Gal3 to Gal80, thus titrating it away from 
binding to the Gal4AD, finally culminating in the increased activation of the GAL genes. 
In order to investigate this further, GAL80 was deleted from the chromosome of the 
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strains used in the study and the phenotype assay was repeated with these cells to test the 








As expected, the ubiquitin mutant H10-Ub D58A displayed a severe growth defect 
on galactose media both in the presence and absence of AA (Fig. 3.3 and Fig. 3.4). This 
severe growth defect was partially suppressed upon the over-expression of Gal3 and 
growth was completely restored upon the deletion of GAL80 (Fig. 3.4). Similar results 
were observed for the remaining histidine-tagged ubiquitin mutants that displayed gal
-
 
phenotypes with the over-expression of Gal3 and the deletion of GAL80 also suppressing 
the growth defects observed when the cells were grown on galactose plates containing 
AA (Fig. 3.3, Fig. 7.7 and Fig. 7.8). These findings imply that the suppressive effect of 
the over-expression of Gal3 is mediated through its interaction with Gal80 and that Gal80 
is in fact the main cause of the severe gal
-
 phenotype observed. Furthermore, the ability 
Figure 3.4. The over-expression of Gal3 and the deletion of GAL80 suppressed the gal
-
 
phenotype of the H10-UbD58A mutant. Tenfold serial dilutions of cells either over-expressing 
Gal3 or lacking GAL80 were spotted onto the depicted plates and incubated at 28°C for 6 days 
to check for the suppression of the gal
-
 phenotype displayed by the cells expressing the mutant 
ubiquitin allele. The Galactose + AA plates contained 1µg/ml AA. (EV: Empty Vector) 
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of the deletion of GAL80 to suppress the gal
-
 phenotypes observed underlines its 
importance in the activation of the GAL genes. 
In order to confirm that the gal
-
 phenotype observed was due to defective 
transcription of the GAL1 gene instead of some other factor, real-time PCR was 





3.5. Transcriptional Activation of the GAL Genes was Defective in the D58A 
Ubiquitin Mutant 
It has thus far been shown that the cells expressing the histidine-tagged D58A 
mutant ubiquitin have a growth defect on galactose plates (Fig. 3.3B). In order to confirm 
that these results were linked to a defect in the transcriptional activation of the GAL 
genes, it was then necessary to perform quantitative real-time PCR to investigate the 
induction of GAL1 mRNA in the cells under the various conditions. 
Published data have shown that GAL1 mRNA is up-regulated by up to 1,000-fold 
within 1 to 2 hours after galactose induction (Swaffield et al., 1992). However, in the 
initial experiments to investigate the induction of GAL1 mRNA upon galactose induction, 
the levels of GAL1 mRNA observed were significantly lower, with induction levels of 
merely 5 to 10-fold over that of the un-induced cells when the cells were induced in 
galactose liquid media for 2 hours.  
As the main difference between the experimental protocol used here and that of the 
previously published findings was that in this study, the cells had been pre-grown in 
glucose liquid media before galactose induction, while the previous studies had used 
either raffinose or other carbon sources that presented de-repressing conditions, it was 
considered that this could be the reason for the drastic difference in induction levels 
observed (Lohr et al., 1995; Muratani et al., 2005). Therefore, it was first necessary to 
investigate the induction kinetics of GAL1 mRNA in cells pre-grown in either raffinose 
or glucose before galactose induction to identify any variations in the length of time 








Figure 3.5. Induction kinetics of GAL1 mRNA in BY4741∆W cells pre-grown with either 
Glucose or Raffinose. BY4741∆W cells were grown in either (A) Glucose liquid media or 
(B) Raffinose liquid media until OD600=1 before being induced in galactose liquid media for 
the indicated times. Total RNA was isolated and GAL1 mRNA was determined relative to 
ACT1 mRNA by quantitative real-time PCR. The value for the un-induced cells was set as 1 
and the error bars indicate the standard deviations between three replicates. 
79 
 
Based on the induction kinetics obtained, it is clear that the induction of GAL1 
mRNA reaches maximal levels only after 8 hours of galactose induction when the cells 
were pre-grown in glucose liquid media. In sharp contrast, a high level of induction was 
observed in cells pre-grown in raffinose liquid media after merely 60 minutes after the 
cells had been transferred into galactose liquid media (Fig. 3.5).  
Since the cells pre-grown in glucose liquid media needed to be induced in galactose 
liquid media for 8 hours before reaching the maximum induction levels, cells that had 
been pre-grown in glucose liquid media were subsequently induced in galactose liquid 
media for 8 hours before being harvested for quantitative real-time PCR to check the 
induction of the GAL1 mRNA in the various cell backgrounds (Fig. 3.5A). 
The expression levels of GAL1 mRNA were investigated in the SUB300 cells 
expressing either histidine-tagged wild-type or D58A mutant ubiquitin in order to 
determine whether the growth defect observed on galactose plates was due to 
transcriptional defects of the GAL1 gene in the strain.  
In addition, as the gal
-
 phenotype displayed by the cells expressing the H10-Ub 
D58A mutant ubiquitin was suppressed by the over-expression of Gal3 and the deletion 
of GAL80, their effects on the transcriptional activation of GAL1 mRNA were also 









The induction of GAL1 was almost completely abrogated in cells expressing the 
histidine-tagged D58A ubiquitin mutant and more importantly, this induction defect was 
partially suppressed by the over-expression of Gal3 and nearly completely suppressed by 
the deletion of GAL80 (Fig. 3.6). This result correlates well with the phenotype assay and 
shows that the growth of the cells on the galactose plates is directly correlated to the 
induction of GAL1 (compare Fig. 3.4 with Fig. 3.6). Furthermore, this result validates the 
hypothesis that the suppression of the gal
-
 phenotype of the cells expressing the histidine-
Figure 3.6. Induction of GAL1 mRNA is defective in SUB300 cells expressing the 
histidine-tagged D58A ubiquitin mutant but can be rescued by the over-expression of 
Gal3 or the deletion of GAL80. SUB300 cells of the indicated genotype expressing the 
indicated ubiquitin alleles were grown in glucose liquid media (Glu) until OD600=1 before 
being induced in galactose liquid media (Gal) for eight hours. Total RNA was isolated and 
GAL1 mRNA was determined relative to ACT1 mRNA by quantitative real-time PCR. The 
value for the un-induced SUB300 cells expressing H10-Ub WT was set as 1 and the error bars 
indicate the standard deviations between three replicates. 
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tagged D58A ubiquitin mutant by the over-expression of Gal3 is mediated through the 




One of the major cellular functions of ubiquitin is its involvement in the ubiquitin 
proteasome system (UPS). As the growth defect observed was a result of the introduction 
of a single point mutation in ubiquitin, the possibility that the mutation in question might 
have adversely affected the ability of ubiquitin to participate in the UPS effectively was 
considered. Since the deletion of GAL80 resulted in the complete restoration of growth on 
galactose media, it was proposed that Gal80 would be the most likely target of the UPS 
and based on this assumption, a cycloheximide protein stability assay was performed to 
determine whether Gal80 would be differentially degraded in cells grown with glucose as 
compared to galactose. 
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3.6. Cycloheximide Stability of Gal80 
In order to investigate the stability of Gal80 cells grown with glucose or with 
galactose, a cycloheximide stability assay was performed. Cycloheximide is an inhibitor 
of protein biosynthesis that is commonly used to investigate the stability of target 
proteins by determination of the cellular levels of proteins in the absence of newly 









Figure 3.7. Gal80 is degraded more quickly in cells grown in galactose liquid media as 
compared to glucose liquid media. BY4741∆W cells expressing HA-Gal80 were grown in 
glucose liquid media until OD600nm=1 before being induced in galactose liquid media for 1 
hour. Cycloheximide (CHX) was added at time=0 and the amount of HA-Gal80 protein 
remaining at each time point was determined by Western blot. The membranes were 
subsequently stripped and stained with Coomassie blue as a loading control before the bands 
were quantified using the ImageJ software (Abràmoff, 2011) and presented as a ratio of HA-
Gal80/Coomassie. The ratio of HA-Gal80/Coomassie at time=0h in both glucose-grown and 
galactose-induced cells was set as 1 and the error bars indicate the standard deviations 
between two replicates. 
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Gal80 is clearly degraded more quickly upon galactose induction than in cells 
grown in glucose liquid media (Fig. 3.7). This indicates that Gal80 needs to be actively 
degraded upon galactose induction as part of the process of activating the GAL genes. 
Based on the finding that Gal80 is degraded more quickly in galactose-induced 
cells than in glucose-grown cells, it was proposed that the histidine-tagged D58A 
mutation in ubiquitin might have adversely affected the degradation of Gal80, thus 
resulting in the severe gal
-
 phenotype observed. As such, the cycloheximide stability 
assay was repeated in the SUB300 strain with cells expressing either histidine-tagged 









Figure 3.8. Gal80 is degraded in galactose-induced cells expressing histidine-tagged wild-
type ubiquitin but stable in cells expressing H10-Ub D58A. SUB300 cells expressing either 
histidine-tagged wild-type or D58A ubiquitin together with HA-Gal80 were grown in glucose 
liquid media until OD600nm=1 before being induced in galactose liquid media for 1 hour. 
Cycloheximide (CHX) was added at time=0 and the amount of HA-Gal80 protein remaining at 
each time point was determined by Western blot. The membranes were subsequently stripped 
and re-probed with α-CPY antibodies before being stripped once more and stained with 
Coomassie blue as loading controls before the bands were quantified using the ImageJ 
software (Abràmoff, 2011) and presented as a ratio of HA-Gal80/CPY. The ratio of HA-
Gal80/CPY at time=0h in both glucose-grown and galactose-induced cells was set as 1 and the 
error bars indicate the standard deviations between two replicates. 
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As expected, Gal80 continued to be degraded more quickly upon galactose 
induction than in the cells grown with glucose in the cells expressing histidine-tagged 
wild-type ubiquitin (Fig 3.8, black bars). However, this differential degradation of Gal80 
was not observed in the cells expressing the histidine-tagged D58A mutant ubiquitin 
allele and Gal80 remained stable even 3 hours after galactose induction (Fig 3.8, gray 
bars). Similarly, Gal80 was found to remain stable in the cells expressing the other 
histidine-tagged ubiquitin mutants that had been identified to display gal
-
 phenotypes 
(Fig. 3.3B and Fig. 7.9). Based on this, we concluded that the D58A mutation was likely 
to have interfered with the degradation of Gal80 and that the stabilization of the protein 
caused the severe gal
-
 phenotype that was observed.  
In addition, it is interesting to note that Gal80 was degraded more quickly in the 
BY4741∆W strain which expressed wild-type ubiquitin directly from the chromosome as 
compared to the SUB300 strain which was expressing histidine-tagged wild-type 
ubiquitin in both glucose-grown cells and galactose-induced cells (compare Fig. 3.7 with 
Fig. 3.8). Since both strains were expressing wild-type ubiquitin, it would have been 
expected that Gal80 would be degraded at similar rates in both strains. However, this was 
clearly not the case and the slower degradation of Gal80 in the SUB300 strain expressing 
histidine-tagged wild-type ubiquitin is likely to be a function of the H10 tag possibly 
interfering with recognition by the proteasome resulting in a delay in the degradation of 
Gal80. 
Nonetheless, it was clear that Gal80 had been stabilized in the cells expressing 
histidine-tagged D58A ubiquitin and that this increased stability of Gal80 is inversely 
correlated with a complete lack of transcriptional activation of GAL1 mRNA in the cells 
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upon galactose induction (compare Fig. 3.6 with Fig. 3.8). Significantly, this lack of 
activation was partially suppressed upon the over-expression of Gal3 in the cells and 
induction of GAL1 was restored to levels comparable to that of the histidine-tagged wild-
type strain in cells lacking the gal repressor protein Gal80 (Fig. 3.6). Taken together, this 
data shows that the growth defect displayed by the cells expressing the histidine-tagged 
D58A ubiquitin mutant is due to a lack of expression of the GAL1 gene resulting from the 





3.7. Mdm30 is the Main F-box Protein Targeting Gal80 for Ubiquitination and 
Degradation 
The ubiquitination of target substrates is mediated by a series of enzymes. These 
are the E1 activating enzyme, the E2 conjugating enzyme and the E3 ubiquitin ligase. In 
particular, the E3 ubiquitin ligases are responsible for transferring the ubiquitin molecule 
from the E2 to a lysine residue on the target protein. At the same time, the E3 is 
responsible for determining substrate specificity. The SCF complex, which consists of 
Skp1, Cul1 and an F-box protein, is one of the best characterized E3 ubiquitin ligases. 
The F-box protein of the SCF complex is responsible for determining substrate specificity 
and 21 genes encoding for F-box proteins have been identified in yeast of which 18 are 
non-essential (Muratani et al., 2005).  
It has been published that cells lacking Mdm30 display a severe growth defect on 
galactose media similar to the effect displayed by the cells expressing the histidine-
tagged D58A ubiquitin mutant (Muratani et al., 2005). In the same paper, the authors 
suggested that the turnover of Gal4 was necessary to allow for full activation of the GAL 
genes. This conclusion, however, was challenged by Nalley et al. (2006) who found that 
Gal4 remained stably bound to the GAL1/GAL10 promoter region and that its turnover 
was not required for the activation of transcription.  
Based on the data thus far presented, it makes sense to consider the possibility that 
it is in fact the degradation of Gal80 that is important to allow for the full activation of 
the GAL genes instead of Gal4, as this conclusion would serve to reconcile the results 
observed by both groups. 
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In order to identify which F-box proteins might be involved in the regulation of 
Gal80, all of the 18 yeast strains, each lacking a non-essential F-box protein, were 
investigated to determine whether they displayed a gal
-




From the phenotypic assay, it was found that in addition to the strain lacking 
Mdm30 that had previously been identified by Muratani et al. (2005), the yeast strains 
lacking Das1 and Ufo1 also displayed growth defects on galactose plates. However, the 
growth defects observed in the strains lacking Das1 or Ufo1 were milder than that 
observed with the strain lacking Mdm30, indicating that Mdm30 is likely to be the main 
F-box protein involved in targeting Gal80 for ubiquitination and degradation (Fig. 3.9). 
This milder phenotype of the ∆DAS1 and ∆UFO1 strains is probably why they were 
missed in the screen performed by Muratani et al. (2005) as the authors had not 
performed a serial dilution and instead had performed their droplet assay with single 
Figure 3.9. The three F-box proteins, Mdm30, Das1 and Ufo1 are required for 
normal growth on galactose plates. Tenfold serial dilutions of cells lacking either 
MDM30, DAS1, or UFO1 were spotted onto the depicted plates and incubated at 28°C for 




spots, which also did not reflect any growth defect in our assay when the neat samples 
were observed (Fig. 3.9, galactose plates, first spot of each sample). 
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3.8. Deletion of GAL80 Specifically Suppressed the gal
-
 Phenotype of the Strain 
Lacking MDM30 
Based on the supposition that Mdm30 is the main F-box protein responsible for 
targeting Gal80 for degradation, the gal
-
 phenotype observed in the ∆MDM30 strain 
would most likely be due to the stabilization of Gal80. Therefore, GAL80 was deleted in 
the strain lacking Mdm30 to check whether the absence of Gal80 in the cells would be 
able to suppress the growth defect observed. 
In addition, a ∆GAL11 strain was included as a control. Gal11 is a subunit of the 
core Mediator complex and is known to be an important target of the Gal4AD that is 
recruited during activation of the GAL genes (Jeong et al., 2001; Myers & Kornberg, 
2000). As such, Gal11 lies downstream of both Gal80 and Gal4 in the activation of the 
GAL genes and it would therefore be expected that the deletion of GAL80 should have no 
effect on the gal
-
 phenotype displayed by the strain lacking Gal11 if the suppressive 
effect observed upon the deletion of GAL80 in the cells were specific due to the relieving 
of its repressive effect on Gal4. 
 
 
Figure 3.10. The deletion of GAL80 specifically suppressed the gal
-
 phenotype of the strain 
lacking Mdm30. Tenfold serial dilutions of the indicated cells were spotted onto the depicted 




Figure 3.10 clearly shows that the gal
-
 phenotype displayed by the ∆MDM30 strain 
was fully suppressed by the deletion of GAL80 in a manner similar to the suppression of 
the gal
- 
phenotype of the strain expressing the histidine-tagged D58A ubiquitin mutant. 
Importantly, the deletion of GAL80 was not able to suppress the gal
-
 phenotype of the 
strain lacking GAL11. Based on this, we can conclude that Gal80 acts upstream of Gal4, 
while Gal11 acts downstream of Gal4 in the activation of the GAL genes, and that 
Mdm30 is likely to be an F-box protein responsible for targeting Gal80 for ubiquitination 
and subsequent degradation. 
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3.9. Gal80 is Stable in Cells Lacking MDM30  
Since it had been established that Mdm30 is a likely candidate for the F-box protein 
targeting Gal80 for degradation, it was then necessary to determine whether the deletion 
of Mdm30 resulted in the stabilization of Gal80. If Mdm30 is an F-box protein that 
targets Gal80 for ubiquitination and subsequent degradation, Gal80 should be stabilized 
in its absence. In contrast, if the gal
-
 phenotype displayed by the ∆GAL11 strain was not 
linked to Gal80, then the stability of Gal80 should not be affected in a strain lacking 









Figure 3.11. Gal80 is stabilized in a strain lacking Mdm30 but is degraded normally in a 
strain lacking Gal11. BY4741∆W cells of the indicated genotypes expressing HA-Gal80 
were grown in glucose liquid media until OD600nm=1 before being induced in galactose liquid 
media for 1 hour. Cycloheximide (CHX) was added at time=0 and the amount of HA-Gal80 
protein remaining at each time point was determined by Western blot. The membranes were 
subsequently stripped and stained with Coomassie blue as a loading control before the bands 
were quantified using the ImageJ software (Abràmoff, 2011) and presented as a ratio of HA-
Gal80/Coomassie. The ratio of HA-Gal80/Coomassie at time=0h in both glucose-grown and 
galactose-induced cells was set as 1 and the error bars indicate the standard deviations 
between two replicates. 
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Figure 3.11 clearly shows that Gal80 is specifically stabilized in a strain lacking 
Mdm30. This finding supports our hypothesis that Mdm30 is an F-box protein 
responsible for targeting Gal80 for ubiquitination and degradation. More importantly, 
Gal80 continues to be degraded with kinetics similar to that of the wild-type strain in the 
cells lacking Gal11 (Fig. 3.7 and Fig. 3.11). This is significant because it emphasizes that 
the gal
-
 phenotype displayed by the strain lacking Mdm30 is specifically due to the 
stabilization of Gal80. Taken together, these findings provide further support for the 
hypothesis that Gal80 needs to be degraded in order to allow for full activation of the 




3.10. Deletion of GAL80 Restored the Induction of GAL1 mRNA in the Strain 
Lacking MDM30 
In order to determine if the growth defects on the galactose plates were due to 
defects in the transcriptional activation of the GAL genes, real-time PCR was performed 
to check the induction of GAL1 mRNA in the presence or absence of Mdm30. Once 
again, we would expect that the transcriptional activation of GAL1 mRNA would be 
defective in the cells lacking Mdm30 and that the deletion of GAL80 should relieve the 





Figure 3.12. Deletion of GAL80 restored GAL1 mRNA induction in the strain lacking 
MDM30. BY4741∆W cells of the indicated genotypes were grown in glucose liquid media 
(Glu) until OD600=1 before being induced in galactose liquid media (Gal) for eight hours. 
Total RNA was isolated and GAL1 mRNA was determined relative to ACT1 mRNA by 
quantitative real-time PCR. The value for the un-induced WT cells (Glu) was set as 1 and the 
error bars indicate the standard deviations between three replicates. 
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As expected, the transcriptional activation of GAL1 mRNA was severely defective 
in the ∆MDM30 strain. More importantly, the additional deletion of GAL80 in this 
background completely suppressed the induction defect to levels similar to that of the 
wild-type strain.   
Interestingly, the results presented here are contradictory to those obtained by 
Muratani et al. (2005). While they had found that GAL1 mRNA continues to be highly 
expressed upon galactose induction in a strain lacking Mdm30, the findings of the current 
study clearly show that the loss of Mdm30 results in a complete abolition of GAL1 
mRNA expression upon galactose induction.  
As it had been previously shown that the induction kinetics of GAL1 mRNA differ 
drastically depending on whether the cells had been pre-grown with glucose or with 
raffinose prior to galactose induction, it was considered that this difference might also 
account for the discrepancy in expression of GAL1 mRNA upon galactose induction in a 









3.11. Galactose Induction of GAL1 mRNA in the ∆MDM30 Strain was Restored 
When the Cells were Pre-Grown with Raffinose Instead of Glucose 
In order to determine whether there was any difference in the galactose induction of 
GAL1 mRNA when the ∆MDM30 cells were pre-grown with raffinose instead of glucose, 
real-time PCR was repeated with cells pre-grown with raffinose to investigate the 








Figure 3.13. Galactose induction of GAL1 mRNA was restored when the cells were 
pre-grown with raffinose instead of glucose. BY4741∆W cells of the indicated 
genotypes were grown in (A) glucose liquid media (Glu) or (B) raffinose liquid media 
(Raf) until OD600=1 before being induced in galactose liquid media (Gal) for eight hours 
or one hour respectively. Total RNA was isolated and GAL1 mRNA was determined 
relative to ACT1 mRNA by quantitative real-time PCR. The value for the un-induced cells 





Induction of GAL1 mRNA was partially restored when the cells were pre-grown 
with raffinose instead of with glucose before the galactose induction (Fig. 3.13). This 
nicely explains the discrepancy between the findings presented in this study and those of 
Muratani et al. (2005). At the same time, this raised the question as to whether Gal80 still 
remained stable in the ∆MDM30 strain upon galactose induction when the cells were pre-
grown with raffinose instead of glucose. A cycloheximide stability assay was therefore 
performed on both the wild-type and ∆MDM30 strains to investigate the stability of HA-
Gal80 in cells pre-grown with raffinose.  
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3.12. Gal80 was Degraded in the ∆MDM30 Strain Upon Galactose Induction When 
the Cells were Pre-Grown with Raffinose 
In order to investigate the stability of Gal80 in the ∆MDM30 strain when the cells 
were pre-grown with raffinose instead of with glucose, the cycloheximide stability assay 
was repeated in the BY4741∆W strain with cells pre-grown in raffinose liquid media 










Figure 3.14. Gal80 was degraded in a strain lacking Mdm30 upon galactose induction 
when the cells were pre-grown with raffinose. BY4741∆W cells of the indicated genotypes 
expressing HA-Gal80 were grown in raffinose liquid media until OD600nm=1 before being 
induced in galactose liquid media for 1 hour. Cycloheximide (CHX) was added at time=0 and 
the amount of HA-Gal80 protein remaining at each time point was determined by Western 
blot. The membranes were subsequently stripped and re-probed with α-CPY antibodies before 
being stripped once more and stained with Coomassie blue as loading controls before the 
bands were quantified using the ImageJ software (Abràmoff, 2011) and presented as a ratio of 
HA-Gal80/CPY. The ratio of HA-Gal80/CPY at time=0h in both raffinose-grown and 
galactose-induced cells was set as 1 and the error bars indicate the standard deviations 




Consistent with the finding that transcription of the GAL1 gene was activated in the 
∆MDM30 strain upon galactose induction when the cells were pre-grown with raffinose 
(Fig. 3.13), it was found that Gal80 was degraded upon galactose induction in cells 
lacking Mdm30 when the cells were been pre-grown with raffinose instead of remaining 
stable as had been the case when the cells were pre-grown with glucose (compare Fig. 
3.11 with Fig. 3.14). Importantly, all of the experiments clearly correlate an increase in 
the stability of Gal80 with a lack of transcriptional activation of the GAL1 gene upon 




3.13. Gal80 Interacts with Skp1 and Mdm30 In Vivo 
Although we showed that Mdm30 is important for the degradation of Gal80 and 
that the deletion of Gal80 can relieve the lack of transcriptional activation of the GAL1 
gene upon galactose induction in the absence of Mdm30, no data has yet been presented 
to show that this is related to the function of Mdm30 as an F-box protein and not a result 
of some other function of Mdm30.  
Based on the hypothesis that Mdm30 targets Gal80 for ubiquitination and 
subsequent degradation, it would be reasonable to assume that Gal80 interacts with 
Mdm30 as well as the other components of the SCF complex in vivo. As such, a co-
immunoprecipitation (Co-IP) assay was performed to check whether Gal80 interacts in 
vivo with Skp1 and Mdm30, which are components of the SCF E3 ubiquitin ligase.  
In order to determine whether Gal80 interacts with either Skp1 or Mdm30 in vivo, it 
was first necessary to identify suitable protein tags for use in the pull-down and 
subsequent Western blot. Therefore, the Co-IP assay was first optimized using Gal80. 
Gal80 is known to dimerize in vivo and therefore, various protein tags could be used to 
pull-down Gal80 before a Western blot was performed to probe for a differentially tagged 
form of Gal80 to confirm whether the pull-down had worked (Pilauri et al., 2005). 
Various Gal80 constructs were generated by fusing Gal80 to protein tags such as GST, 
Myc and H10 which are commonly used to pull-down target proteins. From this, the GST 
pull-down was found to be highly efficient and GST-Gal80 was significantly enriched. 
After it had been determined that GST-Gal80 could be efficiently pulled-down, and 
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successfully visualized via Western blot, the same experimental setup could then be used 
to investigate whether Gal80 interacts with Skp1 and Mdm30 in vivo.  
 
 
Figure 3.15. Gal80 interacts with Skp1 in vivo. BY4741∆W cells expressing GST or 
GST-Gal80 and Skp1-HA3-H10 were grown in glucose liquid media (Glu) until 
OD600nm=1 before being induced in galactose liquid media (Gal) for 2 hours. The cells 
were lysed by bead beating and whole cell extract was prepared. GST or GST-Gal80 was 
pulled-down and a Western blot was performed that was probed with an anti-HA 
antibody to check for interaction of Gal80 with Skp1. The membranes were subsequently 









Figure 3.16. Gal80 interacts with Mdm30 in vivo. BY4741∆W cells expressing GST or 
GST-Gal80 and HA3-Mdm30 were grown in glucose liquid media (Glu) until OD600nm=1 
before being induced in galactose liquid media (Gal) for 2 hours. The cells were lysed by 
bead beating and whole cell extract was prepared. GST or GST-Gal80 was pulled-down 
and a Western blot was performed that was probed with an anti-HA antibody to check for 
interaction of Gal80 with Mdm30. The membranes were subsequently stripped and stained 




Based on the pull-down assay, it is clear that Gal80 specifically interacts with both 
Skp1 and Mdm30 in vivo as the both Skp1 as well as Mdm30 co-immunoprecipitated 
together with GST-Gal80 and not GST alone (Fig. 3.15 and Fig. 3.16). Furthermore, 
Gal80 and Mdm30 were shown to interact at approximately equal amounts (Fig. 3.16, 
Coomassie blot). Since Gal80 interacts with both Skp1 as well as Mdm30, and Mdm30 is 
a known F-box protein, it would be reasonable to conclude that the interactions observed 
were due to Mdm30 binding to Gal80 and as a result linking it to the SCF
Mdm30
 E3 
ubiquitin ligase, which mediates its ubiquitination. 
After it had been shown that Gal80 needs to be degraded in order to allow for the 
full transcriptional activation of the GAL genes and also that it interacts with the 
SCF
Mdm30




3.14. Gal80 is Poly-Ubiquitinated In Vivo 
In order to study whether Gal80 was ubiquitinated in vivo, a pull-down assay was 
performed. H10-Ub was expressed as the sole source of ubiquitin in the SUB288∆WL 
strain and all ubiquitinated proteins were immunoprecipitated using nickel (Ni
2+
) beads. 
Subsequently, the proteins were separated on an SDS-PAGE gel and a Western blot was 
performed and probed with an α-HA antibody to check for the presence of ubiquitinated 
HA-Gal80.  
Untagged ubiquitin (Ub) was included as a negative control to confirm that the 
pull-down was specific for H10-tagged ubiquitin. Additionally, the ∆MDM30 strain was 
included in order to investigate whether there would be any discernible difference in the 








Gal80 was found to be poly-ubiquitinated in vivo in both the wild-type as well as 
the ∆MDM30 backgrounds in the presence of either glucose or galactose (Fig. 3.17). It 
must be noted that un-modified Gal80 was purified along with the ubiquitinated and 
poly-ubiquitinated forms of the protein. This was unexpected as the pull-down was 
specific for the H10-tagged ubiquitin. Nonetheless, this can be explained by the 
dimerization of one molecule of un-modified Gal80 to another ubiquitinated molecule of 
Gal80 (Fig. 3.15; Melcher and Xu, 2001; Pilauri et al., 2005). The two molecules would 
therefore be pulled-down together and then resolved on the SDS gel, resulting in the 
presence of the band corresponding to un-modified Gal80. 
Figure 3.17. Gal80 is poly-ubiquitinated in vivo. SUB288∆WL cells of the indicated 
genotypes expressing Ub WT or H10-Ub WT and HA-Gal80 were grown in glucose liquid 
media (Glu) until OD600nm=1 before being induced in galactose liquid media (Gal) for 2 hours. 
The cells were lysed by bead beating and whole cell extract was prepared before all 
ubiquitinated proteins were pulled-down with Nickel (Ni
2+
) beads. A Western blot was 
performed that was probed with an anti-HA antibody to check for the presence of HA-Gal80. 
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The observation that Gal80 is ubiquitinated in vivo serves to support the previous 
finding that Gal80 is degraded and also that it interacts with the SCF
Mdm30
 complex. 
Furthermore, there seems to be slightly more ubiquitinated Gal80 upon galactose 
induction in both the wild-type as well as the ∆MDM30 strains. In addition, it is clear that 
only a minute fraction of Gal80 is ubiquitinated in the cell (Fig. 3.17, compare 1% input 
bands with Ni-PD bands). As such, it is proposed that the ubiquitination of Gal80 is the 
rate-limiting step in the degradation of Gal80 and that once ubiquitinated, it is 
immediately degraded. This hypothesis is supported by the finding that there is only a 
small difference in the amount of ubiquitinated Gal80 in galactose-induced cells as 
compared to in glucose-grown cells, even though Gal80 is degraded much more quickly 
upon galactose induction.  
It was somewhat intriguing that although Gal80 was stabilized in cells lacking 
Mdm30 (Fig. 3.11), the deletion of Mdm30 did not significantly reduce the level of 
ubiquitination of Gal80. Nonetheless, the continued ubiquitination of Gal80 in the 
absence of Mdm30 serves to confirm the finding that Mdm30 is not the only F-box 
protein involved in the targeting of Gal80 for ubiquitination and degradation. As shown 
previously, cells lacking the F-box proteins, Das1 or Ufo1 also displayed a gal
-
 
phenotype (Fig. 3.9). This implies that these two F-box proteins might also be involved in 
the regulation of Gal80 and therefore, a cycloheximide assay was performed to 
investigate the stability of Gal80 in cells lacking either Das1 or Ufo1. 
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3.15. Gal80 was Stable in Cells Lacking DAS1 or UFO1 
In order to investigate whether the F-box proteins Das1 and Ufo1 also played a role 
in the galactose-stimulated protein degradation of Gal80, a cycloheximide assay was first 
performed with cells lacking either Das1 or Ufo1 to determine whether Gal80 was 








Figure 3.18. Gal80 was stabilized in strains lacking either Das1 or Ufo1. BY4741∆W cells 
of the indicated genotypes expressing HA-Gal80 were grown in glucose liquid media until 
OD600nm=1 before being induced in galactose liquid media for 1 hour. Cycloheximide (CHX) 
was added at time=0 and the amount of HA-Gal80 protein remaining at each time point was 
determined by Western blot. The membranes were subsequently stripped and stained with 
Coomassie blue as a loading control before the bands were quantified using the ImageJ 
software (Abràmoff, 2011) and presented as a ratio of HA-Gal80/Coomassie. The ratio of HA-
Gal80/Coomassie at time=0h in both glucose-grown and galactose-induced cells was set as 1 
and the error bars indicate the standard deviations between two replicates. 
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Similar to what was observed in the cells lacking Mdm30, Gal80 was clearly 
stabilized in cells lacking either Das1 or Ufo1 upon galactose induction (Fig. 3.11 and 
Fig 3.18). This shows that besides Mdm30, Gal80 is also targeted by these two F-box 
proteins. These parallel pathways would therefore provide an explanation as to why 
Gal80 was still found to be ubiquitinated in the cells lacking Mdm30.  
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3.16. Over-expression of Mdm30 or Ufo1 Suppressed the gal
-
 Phenotype of the 
∆DAS1 Strain 
Based on the understanding that Mdm30, Das1 and Ufo1 are each able to target 
Gal80 for ubiquitination and degradation, it should be possible to suppress the gal
-
 
phenotype observed upon the deletion of one of the F-box proteins by over-expressing 
one of the other F-box proteins. Mdm30 and Ufo1 were therefore over-expressed in a 
∆DAS1 strain to investigate whether their over-expression was sufficient to suppress the 
gal
-





Cells lacking DAS1 display a gal
-
 phenotype (Fig. 3.9 and Fig. 3.19). However, this 
gal
-
 phenotype was fully suppressed by the over-expression of either Mdm30 or Ufo1 in 
the cells. This finding serves to strengthen the hypothesis that the three F-box proteins 
Mdm30, Das1 and Ufo1 are all involved in targeting Gal80 for ubiquitination and 
degradation via parallel pathways. 
Figure 3.19. Over-expression of Mdm30 or Ufo1 suppressed the gal
-
 phenotype of the 
∆DAS1 strain. Tenfold serial dilutions of BY4741∆W cells of the indicated genotypes 
expressing the indicated plasmids were spotted onto the depicted plates and incubated at 
28°C for 6 days to check for growth defects on galactose plates. The Galactose + AA plates 





3.17. Un-inducible Gal80 Mutants 
Regulated protein stability is a relatively recent field of study and the signals 
targeting each protein for degradation are still poorly understood. These signals are 
commonly referred to as degrons. Degrons include the N-terminal amino acid of a protein 
(N-end rule), N-terminal acetylation, N-terminal ubiquitination, PEST sequences, 
phosphorylation and cyclin destruction boxes (Ciechanover and Ben-Saadon, 2004; 
Hwang et al., 2010; Ravid and Hochstrasser, 2008; Rogers et al., 1986; Varshavsky, 
1992; Yamano et al., 2004). In order to prevent non-specific degradation of target 
proteins, these signals are often conditional whereby they need to be activated before the 
protein is targeted for degradation. This can be achieved by the dissociation or 
association of subunits, protein unfolding or post-translational modification (Ravid and 
Hochstrasser, 2008). 
As many proteins possess an N-terminal degron, a deletion analysis was performed 
with Gal80, in order to investigate this possibility and to attempt to generate a stable form 
of Gal80 that could be used to further characterize the protein as well as to better study its 
stabilization in the absence of Mdm30 or in the presence of the histidine-tagged D58A 
ubiquitin mutant independently of other gene deletions. Amino acids were sequentially 
deleted from the N-terminus of Gal80, two at a time, and the resulting mutants were 
tested for growth defects on galactose media containing Antimycin A. Additionally, three 
Gal80 mutants, Gal80 G301R, Gal80 G323R and Gal80 E351K that had previously been 
published to be unable to interact with Gal3, resulting in severe gal
-
 phenotypes were 







The over-expression of Gal80 resulted in a slight gal
-
 phenotype. This is most 
likely due to the presence of an excess of Gal80 in the cell that needed to be removed in 
order to allow for efficient activation of the GAL genes. More importantly, the severity of 
the gal
-
 phenotype observed clearly increased as additional amino acids at the N-terminus 
of Gal80 were deleted. This trend peaked with the cells expressing the HA-Gal80∆N12 
mutant, which displayed the most severe growth defect and additional deletions quickly 
restored growth on galactose to levels identical to that of the strain transformed with the 
Figure 3.20. Gal80 N-terminal deletions and Gal3 interaction-deficient mutants. 
Tenfold serial dilutions of BY4742∆W cells expressing the indicated Gal80 
derivatives were spotted onto the depicted plates and incubated at 28°C for 6 days to 






empty vector. Finally, as expected, the cells expressing the three Gal80 mutants that had 
been previously identified to be unable to interact with Gal3 were completely unable to 
grow on the galactose media, confirming the published results (Fig. 3.20). 
As previously discussed, N-terminal modifications are linked to many known 
degradation signals and therefore, it is likely that the N-terminal deletions of Gal80 
resulted in the stabilization of the protein, thus causing the gal
-
 phenotype observed. In 
order to investigate this hypothesis, a cycloheximide stability assay was performed with 
the HA-Gal80∆N12 mutant. As an additional control, the Gal80 G301R mutant was 
included in the stability assay as it would be expected to continue to be degraded since 
the gal
-
 phenotype of the cells expressing the Gal80 G301R mutant is due to the lack of 









Figure 3.21. The deletion of the 12 N-terminal amino acids of Gal80 stabilized the protein 
while the G301R mutant was degraded normally. BY4741∆W cells expressing either HA-
Gal80∆N12 or HA-Gal80 G301R were grown in glucose liquid media until OD600nm=1 before 
being induced in galactose liquid media for 1 hour. Cycloheximide (CHX) was added at 
time=0 and the amount of HA-Gal80 protein remaining at each time point was determined by 
Western blot. The membranes were subsequently stripped and stained with Coomassie blue as 
a loading control before the bands were quantified using the ImageJ software (Abràmoff, 
2011) and presented as a ratio of HA-Gal80/Coomassie. The ratio of HA-Gal80/Coomassie at 
time=0h in both glucose-grown and galactose-induced cells was set as 1 and the error bars 





The deletion of the 12 N-terminal amino acids from Gal80 resulted in its 
stabilization and it was not degraded upon galactose induction as expected (Fig. 3.21). 
This stabilization correlated well with the severe gal
-
 phenotype displayed by the cells 
expressing the HA-Gal80∆N12 mutant and clearly showed that it was possible to cause 
the cells to display a severe gal
-
 phenotype simply by specifically stabilizing Gal80 in the 
cells (Fig. 3.20). In addition, the HA-Gal80 G301R mutant, whose gal
-
 phenotype 
resulted from its inability to interact with Gal3, continued to be degraded with kinetics 
similar to that of wild-type HA-Gal80 even though the cells expressing it were 
completely unable to grow on the galactose plates (Fig. 3.7 and Fig. 3.21). Taken 
together, these findings indicate that the increased stability of Gal80 directly caused the 
gal
-
 phenotype observed instead of Gal80 having been stabilized via some unknown 
mechanism arising from the lack of growth on galactose media.  
This experiment also helped to show that the gal
-
 phenotypes previously observed 
in the strain expressing the H10-Ub D58A mutant as well as those lacking the F-box 
proteins Mdm30, Das1 or Ufo1 are most likely to be a direct result of the stabilization of 
Gal80 in those strains and not due to some other effect caused by the expression of a 
mutant ubiquitin allele or the deletion of an F-box protein that affects some other cellular 
processes.  
Interestingly, the deletion of N-terminal residues of Gal80 beyond the initial 12 
residues quickly caused a reversal of the gal
-
 phenotype observed and growth was 
restored to levels similar to that of the strain expressing the empty vector. In order to 








The N-terminal domain of Gal80 consists of a small number of disordered amino 
acids at the start of the protein followed by the first beta strand of the Rossmann fold 
(Fig. 3.22). As the N-terminus of Gal80 is exposed, it is possible that it could encode a 
degron that is modified to target Gal80 for degradation. Furthermore, N-terminal 
Figure 3.22. Crystal structure of S. cerevisiae Gal80. The monomer of Gal80p is comprised 
of three domains. The N-terminal domain (in blue) consists of a Rossmann fold, the C-
terminal domain (purple) with a prominent β-sheet forms the dimer interface, and a third 
domain (green) extends from the C-terminal domain toward the cleft. Disordered regions are 
shown as a dashed coil. From Kumar, P.R., Yu, Y., Sternglanz, R., Johnston, S.A., and 
Joshua-Tor, L. (2008). NADP regulates the yeast GAL induction system. Science. 319, 1090-
1092. Reprinted with permission from AAAS.  
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deletions in Gal80 beyond its first 12 amino acids might alter the first beta strand of the 
Rossmann fold and could conceivably affect its ability to bind NADP, thus adversely 
affecting the function of the protein (Fig. 3.22 and Fig. 7.10). This would therefore 
provide a likely explanation as to why the additional deletions in Gal80 resulted in a loss 
of the gal
-





3.18. Over-expression of Mdm30 Suppressed the gal
-
 Phenotype Caused by the 
Over-expression of Gal80 
Based on the hypothesis that Mdm30 is the main F-box protein involved in 
targeting Gal80 for ubiquitination and subsequent degradation, it would have been 
expected that less ubiquitinated Gal80 should have been observed in the absence of 
Mdm30. Unfortunately, this was not the case as approximately equal amounts of 
ubiquitinated Gal80 was observed in both the presence and absence of Mdm30 (Fig. 
3.17). As previously discussed, the continued ubiquitination of Gal80 is most likely due 
to the presence of the two other F-box proteins, Das1 and Ufo1 that are capable of 
ubiquitinating Gal80. Furthermore, it is believed that the degradation of Gal80 is limited 
by the ubiquitination of the protein and once ubiquitinated, Gal80 is quickly targeted by 
the proteasome and degraded efficiently. 
It had been noted that Gal80 was found to be stabilized in the absence of Mdm30 
(Fig. 3.11). Additionally, it had been observed that the over-expression of HA-Gal80 in 
cells resulted in a growth defect on galactose plates (Fig. 3.20). Based on the supposition 
that Mdm30 targets Gal80 for ubiquitination and subsequent degradation, the over-
expression of Mdm30 should result in a reduction of Gal80 in cells and this should in turn 
relieve the growth defect associated with the over-expression of HA-Gal80.  In order to 
investigate this, the phenotype of cells over-expressing either Gal80 or Mdm30 alone, or 







Over-expression of Gal80 alone clearly resulted in a gal
-
 phenotype while the over-
expression of Mdm30 did not affect cellular growth (Fig. 3.20 and Fig. 3.23). The growth 
defect observed upon the over-expression of Gal80 alone was most likely due to the 
inability of cell to degrade the excess Gal80 efficiently, thus resulting in the repression of 
the GAL genes upon Gal80 binding to the Gal4AD. Importantly, the over-expression of 
Mdm30 together with Gal80 served to relieve the gal
-
 phenotype observed, showing that 
Mdm30 had the effect of helping to clear at least some of the excess Gal80 from the cell. 
 
Figure 3.23. Over-expression of Mdm30 suppressed the gal
-
 phenotype of cells over-
expressing Gal80. Tenfold serial dilutions of (A) BY4741∆W or (B) SUB288∆WL + Ub WT 
cells expressing the indicated proteins were spotted onto the depicted plates and incubated at 
28°C for 6 days to check for growth defects on galactose plates. The Galactose + AA plates 






3.19. Over-expression of Mdm30 Caused a Glucose Repression Defect 
It was observed that there had been a moderate amount of GAL1 mRNA expressed 
when cells lacking Gal80 were grown in glucose liquid media (Fig. 3.6 and Fig. 3.12). 
This expression of GAL1 mRNA in cells grown under repressive conditions is caused by 
a glucose repression defect resulting from the absence of Gal80 in the cell (Lamphier and 
Ptashne, 1992). As previously discussed, one function of Gal80 is to repress the 
expression of the GAL genes when the cells are grown in glucose. In the presence of 
glucose, Gal80 binds to the Gal4AD and prevents it from activating the GAL genes. This 
repression is so efficient that there is nearly no expression of the GAL genes at all when 
the cells are grown in glucose (Adams, 1972; Melcher and Xu, 2001).  
Supposing Mdm30 targets Gal80 for ubiquitination and subsequent degradation, the 
over-expression of Mdm30 should result in a deficiency of Gal80 in the cells, thus 
leading to a loss of repression, and the GAL genes being expressed even in the presence 
of glucose. In order to study this, the PGAL1-URA3 reporter construct was utilized (Fig 
3.24). This construct carries the URA3 reporter gene under the control of the GAL1 
promoter and can be used to study the conditions under which the GAL1 promoter is 
repressed or expressed by checking for expression of the URA3 gene which is counter-
selectable (Boeke et al., 1987; Hirst et al., 2001). When URA3 is expressed, the cells are 
able to survive on plates lacking uracil. Conversely, the expression of URA3 sensitizes 
the cells to the presence of 5-FOA as 5-FOA is metabolized into the toxic compound 5-
fluorouracil by the enzyme orotidine-5-phosphate decarboxylase which is the gene 
product of URA3. In this way, growth conditions that result in either the expression or 
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repression of the GAL1 promoter can be identified by plating the cells either on media 




The PGAL1-URA3 reporter construct was integrated into the GAL1 locus of the 
BY4741∆W strain and the cells were transformed with either an empty vector (EV) or 
plasmids expressing either tagged or untagged forms of Mdm30. Under repressing 
conditions such as when the cells are grown on glucose media, the Gal80 repressor is 
expected to bind tightly to the Gal4AD and inhibit transcription of the URA3 gene (Fig. 
3.24B). As such, the cells should be unable to grow on plates lacking uracil while at the 
same time being able to survive on plates containing 5-FOA. 
 
Figure 3.24. Schematic of the PGAL1-URA3 reporter construct. The URA3 gene is 
cloned into a plasmid under the control of the GAL1 promoter and Gal4 binds to the 
UASGAL1. (A) In the absence of Gal80, Gal4 is free to activate the URA3 gene. (B) When 






As expected, the cells that were transformed with the empty vector grew poorly on 
plates lacking uracil, while being able to grow on plates containing 5-FOA due to 
efficient repression of the URA3 gene. However, the reverse was true for the cells over-
expressing Mdm30 as those cells were able to grow on the plates lacking uracil and were 
inviable on the plates containing 5-FOA (Fig. 3.25). This meant that URA3 was expressed 
in those cells and that the inhibition of the GAL1 promoter was defective. Based on this 
observation, it is clear that Mdm30 targets Gal80 for degradation and that the resulting 
shortage of the Gal80 repressor protein in the cells is the cause of the glucose repression 
defect observed.  
Figure 3.25. Cells over-expressing Mdm30 displayed a glucose repression defect. Tenfold 
serial dilutions of BY4741∆W cells into which the PGAL1-URA3 reporter construct had been 
integrated expressing the indicated proteins were spotted onto the depicted plates and 
incubated at 28°C for 3 days to check for glucose repression defects. (EV: Empty Vector)  
127 
 
3.20. Over-expression of Mdm30 Reduced the Level of Gal80 Present in Cells 
While attempts to directly observe changes in the ubiquitination pattern of Gal80 in 
the presence or absence of Mdm30 have been unsuccessful, the ability of the over-
expression of Mdm30 to suppress the gal
-
 phenotype associated with the over-expression 
of Gal80 (Fig. 3.23) and to cause a glucose repression defect (Fig. 3.25) clearly indicate 
that Mdm30 is able to cause Gal80 to be degraded in the cells. In order to investigate this 
further, cells over-expressing HA-Gal80 were transformed with either a control plasmid 
or with a plasmid over-expressing Mdm30 and cell extract prepared before the proteins 
were separated via SDS-PAGE and a Western blot performed in order to determine the 







The level of HA-Gal80 present in the cell extract is significantly lower in the cells 
expressing Mdm30 as compared to the cells expressing the control plasmid (Fig. 3.26). 
This provides further evidence to show that Mdm30 is able to target Gal80 for 
ubiquitination and subsequent degradation. 
Figure 3.26. HA-Gal80 protein levels were significantly reduced upon over-expression 
of Mdm30. SUB288∆WL cells over-expressing HA-Gal80 were transformed with either an 
empty vector (EV) or a plasmid over-expressing Mdm30. Cells were grown to OD600=1.0 
before cell extract was prepared and a Western blot performed to check the levels of HA-
Gal80 present. Two different exposures of the same HA-Gal80 blot are provided for better 
visualization of the protein. 
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Taken together, the findings of this study clearly show that Gal80 has to be 
degraded in order to allow for the full activation of the GAL genes. The fact that the 
deletion of GAL80 in many of the cells was able to completely suppress nearly all of the 
gal
-
 phenotypes observed indicates that Gal80 is the main cause of the defects in 
transcriptional activation of the GAL genes. Furthermore, it has been found that the F-box 
proteins Mdm30, Das1 and Ufo1 are all capable of mediating the ubiquitination of Gal80. 
However, it is believed that Mdm30 is the main F-box protein responsible for the 
degradation of Gal80 in the cells and as such Mdm30 has remained the main focus of 








Ubiquitin is a highly conserved essential protein that is present in all eukaryotes. 
Such a high degree of conservation across the large evolutionary divide is clearly 
indicative of the importance of each residue of ubiquitin.  
In this project, it was believed that by using mutant ubiquitin alleles that each 
differed by a single amino acid, it would be possible to garner some insight into the 
functions of ubiquitin in the cell. In particular, the focus was on how ubiquitin affects 
transcription as the ubiquitination of histones and other proteins is an integral part of 
transcriptional control.  
The GAL gene system was eventually selected due to the severe gal
-
 phenotype 
observed with many of the ubiquitin point mutants indicating that ubiquitin plays an 
integral role in the mediation of transcription of the GAL genes. Furthermore, even 
though the GAL gene system has been well characterized, there are many questions still 
left unanswered and conflicting data has been published thus making it particularly 
attractive as a topic of study. 
The mutant ubiquitin alleles were expressed as the sole source of ubiquitin in a 
yeast strain in which all four chromosomal copies of ubiquitin had been deleted. UBI1, 
UBI2 and UBI3 express fusion proteins with one ubiquitin molecule at the N-terminus 
fused to a ribosomal protein, while UBI4 encodes a tandem array of five ubiquitin 
molecules. In each of these fusions, the ubiquitin coding portion of the gene had been 
precisely deleted and wild-type ubiquitin was expressed from a URA3 marked plasmid, 
thus allowing mutant ubiquitin alleles to be easily investigated for their ability to 
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complement the essential functions of wild-type ubiquitin upon plasmid shuffling to 
replace the plasmid expressing wild-type ubiquitin with a plasmid from which a mutant 
ubiquitin allele is expressed (Boeke et al., 1987; Finley et al., 1994; Özkaynak et al., 
1987). 13 untagged mutant alleles and 22 H10-tagged mutant alleles were unable to 
complement the essential functions of ubiquitin. This discrepancy between the two 
groups of ubiquitin alleles is clearly a function of the H10-tag and is likely to indicate that 
the mutant alleles that were only affected upon the addition of the H10-tag might have 
slightly less critical roles to play in the structure or function of ubiquitin as compared to 
those that were unable to complement in the absence of the tag. Of the mutants that were 
unable to complement the essential functions of wild-type ubiquitin, it can be 
hypothesized that these residues have vital roles to play in the function of ubiquitin and at 
least for some of these residues we can clearly see that this is indeed the case. For 
example, K48 is well known to be important in the formation of poly-ubiquitin chains 
that are necessary for targeting substrates for degradation by the UPS (Ciechanover, 
2005; Varshavsky, 1997). Mutations in the C-terminus of ubiquitin are likely to affect the 
formation of poly-ubiquitin chains and thus might also affect the cell in a manner similar 
to the loss of K48. In addition, the residues L8, I44 and V70 that comprise the 
hydrophobic patch on ubiquitin and L67 and L69 which are important in maintaining the 
structure of the hydrophobic core were also unable to support growth upon mutation to 
alanine (Haririnia et al., 2008; Vijay-Kumar et al., 1987). Most of the ubiquitin-binding 
domains identified to date interact with ubiquitin via its hydrophobic patch and therefore 
it is unsurprising that altering those residues resulted in lethality.  
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In the comprehensive phenotype screen, a few mutants were identified as having 
either DNA repair defects or transcription defects. However, it was surprising to find that 
the K63A mutant only displayed a mild growth defect on plates containing MMS even 
though K63-linked poly-ubiquitination has been well-characterized as being important 
for the non-proteolytic roles of ubiquitin, including in the DNA repair pathway. The most 
likely explanation for this is that the concentration of MMS used in the assay was too low 
to cause sufficient DNA damage in the cells to require the activation on the K63-linked 
poly-ubiquitination pathway and this hypothesis is in line with the findings by Spence et 
al. (1995) who had shown that yeast cells expressing a K63R ubiquitin mutant only 
showed a 5-fold reduction in their ability to form colonies in the presence of 0.1% MMS. 
As the introduction of the K63A mutation in ubiquitin does not affect the mono-
ubiquitination of targets such as PCNA and this mono-ubiquitination is known to be 
sufficient for activation of the error-prone replication pathway, the cells should be able to 
continue forming colonies even in the presence of mild DNA damage (Moldovan et al., 
2007).  
Based on the phenotype assay, it was clear that the histidine-tagged mutant 
ubiquitin alleles displayed defects when grown on galactose media containing Antimycin 
A. In particular, the H10-Ub D58A mutant displayed the most severe gal
-
 phenotype and 
was found to grow very poorly on galactose plates even in the absence of AA. D58 of 
ubiquitin had previously been identified as the core residue of a novel, non-canonical 
patch on ubiquitin that is recognized by the ZnF_A20 motif of Rabex-5 (Lee et al., 2006; 
Penengo et al., 2006). This was the first report of a UBD that interacts with a surface of 
ubiquitin other than the I44 patch and Rabex-5 is the only protein that has thus far been 
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identified to interact with the hydrophobic patch centered on D58 (Harper and Schulman, 
2006; Hurley et al., 2006; Husnjak and Dikic, 2012). While Vps9, the yeast ortholog of 
Rabex-5, does not possess the ZnF_A20 UBD, the finding that the single mutation of 
D58 to alanine can have such a dramatic effect on the expression of the GAL genes 
indicates that there might be an unknown protein that possesses the ZnF_A20 motif in 
yeast or perhaps, a novel UBD that also targets the D58 patch of ubiquitin. 
These mutants were then used in unbiased suppressor screens to identify genes 
able to suppress the gal
-
 defects of the various ubiquitin mutant strains and genes isolated 
from the suppressor screens included GAL1, GAL3, YPL257W and genes encoding wild-
type ubiquitin (Figs. 7.3-7.6 and Table 3.2). The isolation of wild-type ubiquitin as a 
suppressor of the gal
-
 phenotype was important as it served to validate the screening 
method used. This is because the phenotype observed was due to a point mutation having 
been introduced into ubiquitin and therefore, wild-type ubiquitin should naturally be 
expected to be able to suppress to phenotype through complementation. In addition, it 
was interesting to find that RPL40A(UBI1) was unable to fully complement for the 
essential functions of ubiquitin in the cell and was not identified in the complementation 
assay used to screen for suppressor plasmids that encoded wild-type ubiquitin (Table 
3.2). One possible explanation for this might be that RPL40A encodes a fusion protein 
consisting of a single molecule of ubiquitin and a ribosomal protein. This single copy of 
wild-type ubiquitin may not produce sufficient ubiquitin to fully complement for the loss 
of ubiquitin in the cell but when it is expressed in  conjunction with the H10-D58A, it is 
able to complement for the activities that the ubiquitin mutant is deficient for and thus 
suppress the gal
-
 phenotype.   
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Among the other suppressors isolated were GAL1, GAL3 and YPL257W. 
YPL257W is a putative gene of unknown function and was not an attractive target to 
study due to a lack of literature regarding the protein (Fig. 7.5). In contrast, GAL1 
encodes a yeast galactokinase and this would be expected to facilitate the growth of the 
cells in the presence of galactose, as galactokinase is the enzyme that catalyzes the first 
step in the Leloir pathway, which is used to metabolize galactose (Holden et al., 2003; 
Schell and Wilson, 1977). In fact, Gal1 has been estimated to make up as much as 2% of 
the total soluble protein in yeast cells growing on galactose and this indicates its 
importance in the ability of yeast to grow in the presence of galactose (Fukasawa et al., 
1979). Gal3, on the other hand, has been found to posses significant sequence similarity 
to Gal1 but interestingly, Gal3 has no galactokinase activity (Bajwa et al., 1988; Bhat et 
al., 1990). Even more interesting is that it had previously been shown that the over-
expression of Gal1 was able to complement for the loss of Gal3 in the cell but not vice 
versa (Bhat et al., 1990). This implies that our finding that GAL1 was able to suppress the 
gal
-
 phenotype displayed by the cells expressing the histidine-tagged D58A ubiquitin 
mutant might actually be due to this activity of Gal1 to complement for the function of 
Gal3 as opposed to being a function of its galactokinase activity. While it is not exactly 
clear whether Gal1 was able to suppress the gal
-
 phenotype due to its galactokinase 
activity or as a result of its ability to complement for the function of Gal3, Gal3 was 
thought to be the more interesting of the two suppressors and therefore further 
investigations were performed to better understand the role of Gal3 in the activation of 
the GAL genes. 
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One of the main functions of Gal3 is its binding to the gal repressor Gal80 in the 
presence of galactose and ATP and disrupting the interaction of Gal80 with the Gal4AD, 
thus allowing Gal4 to activate transcription of the GAL genes (Sil et al., 1999). The exact 
mechanism by which Gal3 disrupts the interaction of Gal80 with the Gal4AD is not 
entirely understood to date but the interaction is vital for the rapid activation of the GAL 
genes upon galactose induction. The current models for the induction of the GAL genes 
propose that the binding of Gal3 to Gal80 either results in its dissociation from Gal4 to 
activate transcription of the GAL genes, or that a conformational change is induced in 
Gal80 that relieves its inhibition of the Gal4AD (Egriboz et al., 2011; Platt and Reece, 
1998). Based on these reports, it was thought to be interesting to study the role of 
ubiquitin in the regulation of the GAL gene switch and this led to GAL3 being made the 
focus of this study. 
The over-expression of Gal3 was found to relieve the gal
-
 defect displayed by the 
cells expressing the histidine-tagged D58A ubiquitin mutant. One of the best known 
functions of ubiquitin in the cells is its involvement in the ubiquitin proteasome system 
(UPS), a major pathway by which the levels of intracellular proteins are controlled by 
regulated protein degradation (Varshavsky, 2005). Based on this, one likely theory would 
be that the gal
-
 phenotype observed was due to a lack of degradation of some target 
protein and that the over-expression of Gal3 caused this requirement to be bypassed. 
Since Gal3 is known to interact with Gal80 and to disrupt its interaction with the 
Gal4AD in order to allow Gal4 to activate the transcription of the GAL genes, Gal80 
would be a likely target for degradation and its stabilization in the presence of the 
histidine-tagged D58A ubiquitin mutant would explain the gal
-
 phenotype observed. In 
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order to study this, the deletion of GAL80 was investigated for its ability to suppress the 
growth defect of the histidine-tagged D58A ubiquitin mutant strain and a cycloheximide 
protein stability assay was performed with Gal80. As expected, the deletion of GAL80 
was able to fully suppress the gal
-
 phenotype of the strain expressing the histidine-tagged 
D58A mutant ubiquitin and even more significantly, Gal80 was found to be degraded 
more quickly upon galactose induction in the wild-type strains but was stabilized in the 
strain expressing the histidine-tagged D58A mutant ubiquitin. Furthermore, in an attempt 
to link this differential degradation to transcription, the levels of GAL1 mRNA were 
determined to examine the transcription of the GAL genes under the various conditions. 
In line with the phenotypic results, GAL1 mRNA levels were found to be completely 
abrogated in cells expressing the histidine-tagged D58A mutant ubiquitin and more 
importantly, this lack of induction was partially suppressed upon the over-expression of 
Gal3 and transcription of GAL1 mRNA was returned to level close to that observed with 
the wild-type strain in cells lacking GAL80. Taken together, these data convincingly 
show that Gal80 has to be degraded upon galactose induction in order to allow for the 
efficient activation of the GAL genes. 
F-box proteins are the component of the E3 ubiquitin ligase complex that confers 
substrate specificity (Patton et al., 1998). It was claimed in a previous study that the 
ubiquitination and degradation of Gal4 mediated by the SCF
Mdm30
 E3 ubiquitin ligase was 
necessary for the activation of the GAL genes (Muratani et al., 2005). Based on this, it 
was believed that Gal80 might also be targeted by an SCF E3 ubiquitin ligase containing 
either Mdm30 or some other F-box protein. As such, in order to better understand the 
mechanism by which Gal80 was degraded, a complete series of yeast F-box deletion 
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strains were investigated. Interestingly, three F-box proteins, Mdm30, Das1, and Ufo1 
were found to be important for the degradation of Gal80, as cells lacking any of these F-
box proteins had a growth defect on galactose plates and Gal80 was found to be 
stabilized in all three gene deletion strains. Furthermore, the additional gene deletion of 
GAL80 in each of these strains suppressed the observed growth defects and the over-
expression of either Mdm30 or Ufo1 suppressed the gal
-
 phenotype of the strain lacking 
DAS1. Importantly, the suppressive effect of the deletion of Gal80 in the strains was 
shown to be specific for targets downstream of Gal4 in the activation of the GAL genes as 
the deletion of GAL80 was unable to suppress the gal
-
 phenotype of a strain lacking the 
Mediator component Gal11 (Med15) which is part of the tail module of the Mediator 
complex and is known to be vital for maximal expression of Gal4 activated genes via its 
interaction with Gal4 (Reeves and Hahn, 2005). 
Gal80 was found to interact with components of the ubiquitination machinery 
such as Skp1 and the F-box protein Mdm30 in vivo in a Co-IP assay. Interestingly, Gal80 
was shown to interact with Skp1 and Mdm30 in cells grown with both glucose as well as 
with galactose, and the amount of Skp1 and Mdm30 pulled down together with Gal80 
seemed to be slightly lower in galactose-induced cells as compared to glucose-grown 
cells. Based on this result, it is probable that the interaction between Gal80 and the 
ubiquitination machinery occurs in cells grown with both glucose and with galactose but 
that the degradation of Gal80 is carbon source specific.  
Based on the finding that Gal80 interacts with the ubiquitination machinery, 
another Co-IP assay was performed to check whether Gal80 was in fact ubiquitinated by 
pulling-down all the ubiquitinated proteins in the cell followed by a Western blot to 
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observe HA-Gal80. As expected, Gal80 was shown to be poly-ubiquitinated in vivo. 
What was surprising, however, was the finding that Gal80 was poly-ubiquitinated in cells 
grown with glucose as well as with galactose and that the levels of poly-ubiquitinated 
Gal80 were not significantly higher in galactose-induced cells as might have been 
expected from the cycloheximide assays showing the differential degradation of the 
protein. This was attributed to ubiquitination of Gal80 being the rate-limiting step in the 
degradation of Gal80 and that the protein is quickly degraded once it has been poly-
ubiquitinated. We had attempted to investigate this possibility further by using 
proteasome deficient strains or proteasome inhibitors to stabilize the ubiquitinated Gal80, 
but unfortunately, were unable to obtain any conclusive results. 
 In order to provide further evidence that the degradation of Gal80 was necessary 
for the activation of the GAL genes and that the gal
-
 phenotype observed in the various 
mutant strains was a direct consequence of the stabilization of Gal80, a stable Gal80 
variant was generated by performing N-terminal deletions of Gal80. In line with the 
previous observations, the over-expression of the stable Gal80 mutant ∆N12 resulted in a 
severe gal
-
 phenotype. While the exact mechanism by which Gal80 is stabilized upon the 
deletion of its 12 N-terminal amino acids is unclear, it is hypothesized that the deletion of 
those residues results in either the loss of some N-terminal degron that is modified upon 
galactose induction to target Gal80 for degradation. Interestingly, the Gal80 mutant, 
Gal80 G301R, was found to be degraded with kinetics similar to that of wild-type Gal80 
although cells expressing Gal80 G301R were unable to grow on galactose plates 
containing Antimycin A. This is because the growth defect displayed by cells expressing 
Gal80 G301R was actually due to the inability of the Gal80 mutant to interact with Gal3 
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(Diep et al., 2008; Nogi et al., 1977; Pilauri et al., 2005). Taken together, these results 
show that both export and degradation of Gal80 are necessary for the full activation of 
the GAL genes as either the stabilization of Gal80 or the inability to export Gal80 from 
the nucleus alone is sufficient to cause the cells to display a growth defect on galactose 
plates containing Antimycin A.  
As Gal80 continued to be ubiquitinated in the absence of Mdm30, most likely due 
to the presence of the two other F-box proteins, Das1 and Ufo1 that were capable of 
targeting Gal80 for degradation, a different strategy was employed to confirm the 
importance of Mdm30 in the degradation of Gal80. To this end, the effects of the over-
expression of Mdm30 on Gal80 and the expression of the GAL genes were investigated. 
It had previously been noticed that cells over-expressing Gal80 had a slight growth defect 
on galactose media. Since the phenotype observed is likely a result of the excess Gal80 
present in the cell, it would be expected that the over-expression of Mdm30 should 
counter this effect and this was exactly the case. Additionally, it had been noted that there 
had been a moderate level of GAL1 mRNA expressed in glucose in the cells lacking 
GAL80 and this was believed to be a function of a deficiency in the glucose repression of 
the GAL genes in its absence. In order to further characterize this, a glucose repression 
assay was designed where a PGAL1-URA3 reporter gene was used. In glucose-grown cells, 
the URA3 gene should be repressed and the cells should not be able to grow in the 
absence of uracil but they should be able to grow in the presence of 5-FOA. However, 
upon the over-expression of Mdm30 in the cells, the reverse was true. This showed that 
the over-expression of Mdm30 targeted Gal80 for degradation and that this lack of Gal80 
in the cell resulted in a glucose repression defect, allowing for the expression of URA3 
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even in the presence of glucose. Finally, this effect of Mdm30 on Gal80 was investigated 
by a Western blot to directly observe the protein levels and we were able to clearly see 
that the levels of Gal80 present in the cell were significantly lower upon the over-
expression of Mdm30. Taken together, these experiments confirm the hypothesis that 
Mdm30 is an F-box protein capable of targeting Gal80 for ubiquitination and 
degradation. 
One thing to note is that it was found that the deletion of MDM30 resulted in the 
complete abrogation of GAL1 induction when the cells were transferred to galactose 
media. This is contrary to the findings by Muratani et al. (2005) who had found that 
GAL1 continued to be induced upon the switch to galactose. One difference between the 
two protocols is that Muratani et al. (2005) had pre-grown their cells in raffinose prior to 
galactose induction, while I had pre-grown the cells in glucose media in order to remain 
consistent with the plate assays, and the possibility that this difference could account for 
the variation in the expression of GAL1 mRNA was considered. As such, the experiments 
were repeated with cells pre-grown with raffinose and it was found that the induction of 
GAL1 mRNA was restored upon transfer to galactose and also that Gal80 was degraded 
much quicker upon galactose induction when the cells were pre-grown with raffinose as 
compared to with glucose. Based on the cycloheximide stability assays, the half-life of 
Gal80 in BY4741∆W cells was calculated to be approximately 3 hours when the cells 
were grown with glucose, 2 hours when they were grown with raffinose, 1 hour in 
galactose-induced cells that had been pre-grown with glucose and 30 minutes in 
galactose-induced cells that had been pre-grown with raffinose. Importantly, the rate of 
induction of GAL1 mRNA in cells pre-grown with raffinose was also significantly faster 
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than in cells pre-grown in glucose, with full galactose induction of GAL1 mRNA 
requiring only 1 hour when the cells had been pre-grown with raffinose, but 4 hours when 
they had been pre-grown with glucose. This correlation between the stability of Gal80 
and the rate of induction implies that the rate at which Gal80 is degraded might be the 
rate-limiting step in the induction of the GAL1 gene. The exact mechanism for the 
continued expression of GAL1 mRNA in the cells lacking Mdm30 when they are pre-
grown with raffinose is unclear but one likely explanation is that the other two F-box 
proteins identified to be involved in the induction of the GAL genes, Das1 and Ufo1, 
could be more active when the cells are grown in raffinose than when the cells are grown 
in glucose. This increased activity would mean that Das1 and Ufo1 could efficiently 
target Gal80 for degradation upon galactose induction, thus compensating for the absence 
of Mdm30 and allowing the expression of the GAL genes.  
In particular, the finding that the full activation of the GAL genes requires the 
degradation of a transcriptional repressor raises the question whether this might be also 
the case for other regulons in which the degradation of the transcriptional activator has 
been proposed to be important for transcriptional activation (Lipford et al., 2005). The 
requirement of the degradation of a transcriptional repressor as a pre-requisite for 
transcriptional activation is an easily understood concept and this has also been found to 
be the case for the Cup9 protein that is rapidly degraded upon induction to allow for the 
activation of PTR2 as well as the Matα2 repressor that is ubiquitinated and rapidly 
degraded to allow for mating-type switching in yeast (Byrd et al., 1998; Laney and 
Hochstrasser, 2003; Richter-Ruoff et al., 1994; Xia et al., 2008).  
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In contrast, Lipford et al. (2005) proposed that the degradation of the 
transcriptional activator Gcn4 might play an important role in transcriptional activation as 
inhibition of the proteasome or the mutation Cdc34, an F-box protein known to target 
Gcn4 for ubiquitination, was found to impair the transcription of Gcn4 targets, indicating 
that the degradation of Gcn4 might be necessary for transcriptional activation. 
Interestingly, Gcn4 is rapidly degraded under non-inducing conditions but stable under 
conditions of amino acid starvation which contradicts this hypothesis (Kornitzer et al., 
1994). Furthermore, the stable Gcn4 mutant, Gcn4 3T2S continues to be able to activate 
transcription in a manner independent of proteasome inhibition (Chi et al., 2001; Lipford 
et al., 2005). Taken together, these findings present the possibility that the transcriptional 
defects on Gcn4 targets observed upon proteasome inhibition might be due the 
stabilization of some other factors such as a transcriptional repressor as a stable form of 
Gcn4 remains able to activate transcription. Nonetheless, it is still possible that the 
specific degradation of transcriptional activators bound to the promoters of their target 
genes might be necessary in order to facilitate transcriptional activation, but the findings 
presented to date are insufficient to definitively prove whether this is in fact the case. 
In summary, the results presented in this thesis clearly show that the degradation 
of Gal80 is necessary to allow for the full activation of transcription of the GAL genes 
and that in the absence of this degradation, induction is defective. This expands the 
current understanding of the GAL gene switch and sheds further light on the importance 
of ubiquitination of substrates in the control of transcription. Furthermore, we were able 
to identify the F-box proteins involved in the targeting of Gal80 for degradation and it is 
interesting to note that, while Mdm30 is believed to be the main F-box protein involved 
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in controlling the levels of Gal80 in the cell, Das1 and Ufo1 are also able to target Gal80 
for degradation.  
Based on the findings presented here, it is proposed that - in addition to either the 
dissociation of Gal80 from Gal4 upon Gal3 binding to Gal80, or the conformational 
change in Gal80 induced by its binding to Gal3 relieving its inhibition of Gal4 (Egriboz 
et al., 2011; Abramczyk et al., 2012) - Gal80 also has to be ubiquitinated and degraded in 
order to achieve full induction of the GAL genes.  
This conclusion is supported by the finding that the Gal80∆N12 mutant that is 
stable upon galactose induction as well as the Gal80 G301R mutant that is deficient for 
the interaction with Gal3 but is quickly degraded upon galactose induction both display a 
gal
-
 phenotype. This therefore indicates that both the interaction of Gal80 with Gal3 as 
well as the degradation of Gal80 is required to facilitate the rapid induction of the GAL 
genes upon the addition of galactose (Fig. 4.1). 
While it is clear that both the interaction of Gal80 with Gal3 as well as the 
degradation of Gal80 is necessary for the rapid induction of the GAL genes upon 
galactose induction, the protein responsible for signaling the degradation of Gal80 is not 
known. One likely candidate for the signal transducer would be the galactose sensor, 
Gal3. However, Gal80 continued to be degraded upon galactose induction in a strain 
lacking Gal3, indicating that the signal transducer had to be some other protein (Fig. 
7.11B and Fig. 7.11C). As such, there still remains much work to be done in order to 







Figure 4.1. Model for transcriptional regulation of GAL1. Upon galactose induction, the 
Gal3 protein binds to Gal80 and relieves its inhibition of the Gal4AD to allow Gal4 to recruit 
the transcriptional machinery. It is proposed that in addition to the binding of Gal3 to Gal80, 
that Gal80 is degraded via the ubiquitin proteasome system to further deplete its levels in the 




I have shown that cells expressing the H10-Ub D58A mutant as the sole source of 
ubiquitin displayed a severe growth defect on galactose media that was suppressed by 
either the over-expression of Gal3 or the additional gene deletion of GAL80. In addition, 
the induction of GAL1 mRNA was defective in this strain, and it was rescued by the over-
expression of Gal3 or the deletion of GAL80.  
Furthermore, I have shown that Gal80 was degraded more quickly in cells grown 
with galactose than with glucose, and also that the rate at which Gal80 was degraded 
upon galactose induction differed significantly depending on whether the cells had been 
pre-grown with glucose or with raffinose. A stable Gal80 mutant was also generated and 
cells expressing this mutant displayed a severe growth defect on galactose plates in the 
absence of any chromosomal mutation. 
Gal80 also interacted with both Skp1 and Mdm30, which are components of the 
ubiquitination machinery, and Gal80 was poly-ubiquitinated in vivo. Furthermore, over-
expression of Mdm30 eliminated Gal80 in the cell, demonstrating that Mdm30 targets 
Gal80 for degradation. 
From these results, it can therefore be concluded that the ubiquitin-mediated 
degradation of Gal80 by the SCF
Mdm30
 E3 ubiquitin ligase complex is necessary for the 
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7.1. Appendix A 
7.1.1. Supplementary Figures 
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Figure 7.1. Comprehensive phenotype screen for the full list of mutant ubiquitin alleles. 
Tenfold serial dilutions of SUB288∆WL cells expressing the indicated ubiquitin alleles were 
spotted onto the depicted plates and incubated at for 6 days. The MMS plates contained 1mg/ml 
MMS, the AT plates contained 50mM AT and the Gal + AA plates contained 1µg/ml AA. 
Controls for the gal





  Figure 7.2. Comprehensive phenotype screen for galactose utilization deficient ubiquitin 
mutants. Tenfold serial dilutions of SUB288∆WL::GAL3 cells expressing the indicated 
ubiquitin alleles were spotted onto the depicted plates and incubated at 28°C for 6 days. The 










Figure 7.3. Chromosome feature map showing the region of chromosome II encoded by 
the isolated suppressor. Gal1 is a galactokinase, it phosphorylates alpha-D-galactose to alpha-
D-galactose-1-phosphate in the first step of galactose catabolism and its expression is regulated 
by Gal4 (http://www.yeastgenome.org/cgi-bin/locus.fpl?locus=gal1). The 5′ and 3′ ends of the 
DNA sequence coded for by the suppressor were identified by sequencing and the chromosome 






Figure 7.4. Chromosome feature map showing the region of chromosome IV encoded by 
the isolated suppressor. Gal3 is a transcriptional regulator involved in activation of the GAL 
genes in response to galactose; it forms a complex with Gal80 to relieve Gal80 inhibition of 
Gal4; it binds galactose and ATP but does not have galactokinase activity 
(http://www.yeastgenome.org/cgi-bin/locus.fpl?locus=gal3). The 5′ and 3′ ends of the DNA 
sequence coded for by the suppressor were identified by sequencing and the chromosome 








Figure 7.5. Chromosome feature map showing the region of chromosome XVI encoded by 
the isolated suppressor. Ypl257w is a putative protein of unknown function; thehomozygous 
diploid deletion strain exhibits a low budding index and it has been shown to physically interact 
with Hsp82; YPL257W is not an essential gene (http://www.yeastgenome.org/cgi-
bin/locus.fpl?dbid=S000006178). The 5′ and 3′ ends of the DNA sequence coded for by the 
suppressor were identified by sequencing and the chromosome feature map was retrieved from 







Figure 7.6. Chromosome feature maps showing the regions of chromosome IX encoded by 
the isolated suppressors. Rpl40a is a fusion protein, identical to Rpl40Bp, that is cleaved to 
yield ubiquitin and a ribosomal protein of the large (60S) ribosomal subunit with similarity to 
rat L40; ubiquitin may facilitate assembly of the ribosomal protein into ribosomes 
(http://www.yeastgenome.org/cgi-bin/locus.fpl?locus=rpl40a). The 5′ and 3′ ends of the DNA 
sequence coded for by the suppressor were identified by sequencing and the chromosome 














Figure 7.7. Over-expression of Gal3 suppressed the gal
-
 phenotype of the histidine-tagged 
ubiquitin mutants. Tenfold serial dilutions of SUB288∆WL::GAL3 cells expressing the 
indicated ubiquitin alleles and either an empty vector (EV) or Gal3 were spotted onto the 






Figure 7.8. Deletion of GAL80 suppressed the gal
-
 phenotype of the histidine-tagged 
ubiquitin mutants. Tenfold serial dilutions of SUB288∆WL::GAL3 or SUB288∆WL::GAL3 
∆GAL80 cells expressing the indicated ubiquitin alleles were spotted onto the depicted plates 






Figure 7.9. Gal80 was stable in cells expressing the histidine-tagged mutant ubiquitin alleles 
upon galactose induction. SUB288∆WL::GAL3 cells expressing the indicated histidine-tagged 
mutant ubiquitin alleles together with HA-Gal80 were grown in glucose liquid media until 
OD600nm=1 before being induced in galactose liquid media for 1 hour. Cycloheximide (CHX) was 
added at time=0 and the amount of HA-Gal80 protein remaining at each time point was determined 
by Western blot. The membranes were subsequently stripped and re-probed with α-CPY antibodies 
before being stripped once more and stained with Coomassie blue as loading controls before the 








Figure 7.10. Schematic of Gal80 showing its predicted domains. The predicted domains of 
Gal80 are highlighted and there is a close-up view of the first 20 amino acids with the 12
th
 amino 




Figure 7.11. Gal80 is degraded upon galactose induction in cells lacking Gal3. Tenfold serial 
dilutions of the indicated cells were spotted onto the depicted plates and incubated at 28°C for 6 
days to check for growth defects on galactose plates (A). BY4741∆W∆GAL3 cells expressing HA-
Gal80 were grown in glucose liquid media until OD600nm=1 before being induced in galactose liquid 
media for 1 hour. Cycloheximide (CHX) was added at time=0 and the amount of HA-Gal80 protein 
remaining at each time point was determined by Western blot. The membranes were subsequently 
stripped and re-probed with α-CPY antibodies before being stripped once more and stained with 
Coomassie blue as loading controls (B) before the bands were quantified using the ImageJ software 














7.2. Appendix B 
7.2.1. Media 
Glucose Liquid Media (1L) 
D-Glucose 20g 
Yeast Nitrogen Base  7g 
Amino Acid Premix 0.7g 
 
Galactose Liquid Media (1L) 
 
 
Raffinose Liquid Media (1L) 
Raffinose 20g 
Yeast Nitrogen Base  7g 




Yeast Extract 5g 
Sodium Chloride 0.7g 
5N Sodium Hydroxide (40g/L) 200µl 
 
YPDA (1L) 
Yeast Extract 10g 
Peptone 20g 
D-Glucose 20g 




Yeast Nitrogen Base  7g 
Amino Acid Premix 0.7g 
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7.3. Appendix C 
7.3.1. Solutions and Buffers 
7.3.1.1. Solutions 
Miniprep Solution I 
Tris-HCl, pH7.5 50mM 
EDTA 10mM 
RNase A 10µg/ml 
 
Miniprep Solution II 
Sodium Hydroxide 0.2M  
SDS 1% (v/v)  
 
Miniprep Solution III 
Sodium Acetate 1.32M 
100% Acetic Acid to adjust pH to pH4.8 
 
Lithium Acetate Solution (0.1M LiAc) 
Lithium Acetate 0.1M 
Tris-HCl 0.01M 





10X FA Gel Buffer 
3-[N-morpholino]propanesulfonic acid (MOPS) 200mM 
Sodium Acetate  50mM 
EDTA 10mM 
Sodium Hydroxide to adjust pH to pH7.0  
 
1X FA Gel Running Buffer 
10X FA Gel Buffer 100ml  
37% Formaldehyde 20ml 
RNase Free Water 880ml 
 
Yeast Lysis Buffer 
Tris-HCl (pH7.5) 10mM 
KCl 50mM 
EDTA 1mM 
NP-40 0.1% (v/v) 
 
Yeast Breaking Buffer 
Tris-HCl (pH8.0) 10mM 
NaCl 100mM 
EDTA 1mM 
SDS 1% (v/v) 










1x Western Blot Transfer Buffer 
5X Western Blot Transfer Buffer 10ml 
Methanol 10ml 
Distilled Water 30ml 
 
Western Blot Blocking Buffer 
Skim Milk 5% (w/v) 
Tris-HCl (pH7.4) 10mM 
Distilled Water 50ml 
 
Tris-Buffered Saline + Tween 20 (TBST) 
Tris 20mM 
NaCl 150mM 
Tween 20 0.1% (v/v) 
 
Western Blot Binding Buffer 
Skim Milk 5% (w/v) 
TBST 50ml 
 
Western Blot Stripping Buffer 
NaOH 0.2M 
 
 
 
 
 
 
